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SUMMARY  
The focus of this work was to establish quantitative structure activity (QSAR, potency of 
allosteric modulators) and property (QSPR, carbon chemical shifts) relations for molecules with 
known structure and activity/property by means of machine learning. These trained machine 
learning models were then employed to predict biological activity and carbon chemical shifts of 
molecules with known structure but unknown biological activity or carbon chemical shifts. All 
described algorithms were implemented in the BioChemistry library (BCL). The BCL is an in-
house object-oriented library providing functionality to manipulate small molecules and proteins.  
Chapter I gives an introduction to the field of QSAR/QSPR with specific consideration of 
machine learning and descriptor development. In chapter II, the application of these principles to 
determine positive allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 
(mGlu5) from a database of commercially available compounds is described. Chapter III details 
the expansion of the methods established in chapter II to promote scaffold-hopping in the search 
for metabotropic glutamate receptor subtype 4 (mGlu4) PAMs. The refinement of the described 
methods led to the discovery of two compounds representing a new scaffold of negative allosteric 
modulators (NAMs) of mGlu5. These results are reported in chapter IV. The prediction of carbon 
chemical shifts by means of a QSPR is reported in chapter V. Chapter VI concludes the main part 
of this document with a discussion of the results presented. The appendix details protocols, file 
structures on the accompanying DVD, and applications employed in establishing the 
QSARs/QSPRs. 
Chapter II is based on „Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators 
Using Virtual High-Throughput Screening‟ which was published 2010 in the American Chemical 
Society journal „Chemical Neuroscience‟1. The content of chapter III will be expanded with 
biological data for the newly identified PAMs for mGlu4 and submitted to the same journal for 
xix 
 
publication. Chapter IV will be incorporated into a paper characterizing the two mGlu5 NAMs 
representing a previously unknown scaffold. Chapter V details research for predicting carbon 
chemical shifts. The first part was submitted as a manuscript to Journal of Chemical Information 
and Modeling. Based on the reviews, it was expanded to include stereochemical descriptors. It 
has not yet been resubmitted. 
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CHAPTER I 
INTRODUCTION 
Quantitative Structure Activity Relationships 
Structure activity relationships are built on the paradigm that structurally similar compounds have 
similar biological activity. Quantitative structure activity relationships (QSARs) connect activity 
to structure by fitting a mathematical function through molecules with known structure and 
activity:                      . Once this relationship is established, it can be employed to 
predict the activity of molecules with known structure but unknown activity. 
Quantitative Structure Property Relationships 
Quantitative structure property relationships (QSPRs) expand the idea of QSAR to predict any 
specific chemical or biological property of a molecule. In this work, the term QSAR is always 
connected to the prediction of biological activity (half maximal effective/inhibitor concentration 
EC50/IC50) of molecules towards allosteric modulation of metabotropic glutamate receptor 
subtype 4 (mGlu4, chapter III) and 5 (mGlu5, chapter II and IV). Alternatively, QSPR describes 
the attempts to predict chemical shifts for carbon atoms of small molecules (<50 heavy atoms) 
based on the structure of the molecule around them.     
QSAR/QSPR through machine learning  
Linear regression analysis is commonly used to establish QSARs/QSPRs. However, this assumes 
that the activity can be described as a linear combination of all the structural descriptors which is 
not necessarily the case. Machine learning tools like artificial neural networks (ANNs) and 
support vector machines can alleviate this problem, since they employ non-linear functions to 
relate input (structure) and output (activity/property). 
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QSAR/QSPR general workflow 
Establishing all four QSARs/QSPRs described here includes the same four steps: i) a database 
connecting molecules with known structure and activity/property needs to be obtained, ii) the 
structure of the molecules is described in a way that is independent from spatial orientation to 
avoid lengthy superimposition of the molecules, iii) training of models (ANNs) through 
supervised back-propagation of errors, iv) predicting properties of molecules without prior 
knowledge of said property. In the case of the allosteric modulators, molecules from 
commercially available databases (ChemBridge/ChemDiv) which were predicted to have 
favorable activity were ordered and tested; for the carbon chemical shift prediction, small 
molecules from the literature were tested towards correct description of their chemical shifts. 
Identifying publicly and commercially available carbon chemical shift data bases 
NMRshiftDB
2
 is a publicly available database that allows scientists to upload NMR spectra with 
assigned shifts. It contains approximately 290,000 unique carbon chemical shifts in 27,800 
spectra (July 2010). A subset of these molecules comprising 178,000 unique carbon chemical 
shifts in 16,500 spectra is provided with three-dimensional coordinates for the atoms. The 
SpecInfo database (2002) contains approximately 1.5 million unique carbon chemical shifts in 
105,000 spectra. Another publicly available chemical shift database is the Spectral Database for 
Organic Compounds (SDBS, approximately 130,000 carbon chemical shifts). Examples for 
commercial shift databases include BIORAD KnowItAll based on the CSEARCH database 
(~4,000,000 carbon chemical shifts), MODGRAPH NMRPredict (~3,500,000 
13
C chemical 
shifts), and ACD/CNMR (~2,160,000 
13
C chemical shifts). 
Local high-throughput screens provided small molecule activity data towards mGlu4/5 
The biological activity data employed in chapters II to IV was collected from two high-
throughput screens performed at the Vanderbilt high-throughput screening center. Both screens 
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were based on triple-add fluorescence calcium flux assays. The results of the mGlu5 screen were 
published by Rodriguez et al in October 2010
3
. The Vanderbilt high-throughput screen results for 
mGlu4 based on work by Niswender et al have not been published yet; however, several papers 
based on this screen came out in the last few years
4
. 
Commercial ADRIANA descriptors were developed into atom-based descriptors 
ADRIANA
5
 is commercially available software that generates descriptors for small molecules. 
These fall into four main categories (eight scalar descriptors, eight 2D/3D-auto correlations each, 
eight radial distribution functions, and three surface auto-correlations). However, in the 
commercial ADRIANA software these descriptors are summed up over all pairs of atoms in the 
molecule. To generalize these descriptors for single atoms they were implemented based on the 
references provided in the ADRIANA manual in the local BioChemistryLibrary (BCL) software 
package. A detailed description of this implementation is given in chapter V. 
Small molecule conformations were computed with CORINA 
Some of the ADRIANA descriptors (3D and surface auto-correlations, radial distribution 
functions) needed low-energy conformations to be computed correctly. These conformations 
were generated with the help of the CORINA
6
 software. Since these conformations only needed 
to be determined once, the CORINA software was not re-implemented. 
Constitutional chemical shift descriptors based on atom/bond types and ring closure 
To describe the constitution surrounding an atom of interest in the carbon chemical shift 
prediction, the code in chapter V is based on atoms sharing a certain bond distance from the atom 
of interest (atom spheres). All atoms with the same atom type (based on element type, 
hybridization, charge) were summed up for each sphere. Furthermore, the code contains 
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information about the bonds that connect any given atom to its previous sphere and the number 
and type of rings closed in each sphere. 
Strong synergy between QSAR and QSPR projects 
The combination of two seemingly different projects like carbon chemical shift prediction and 
determination of biological activity still allows for a strong synergy between both. The number of 
data points is comparable (50,000 – 250,000 for most of the models), the number of inputs is 
similar (300 – 2,000), and the descriptors could be re-implemented to accommodate both whole 
molecules and single atoms. Both data sets were stored in SD files which could be processed with 
a SDF reading function specifically implemented in the BCL. 
Neural Networks as robust tools for QSAR/QSPR 
For a review of the role of neural networks in drug discovery see Winkler et al
7
. It not only 
discusses the way QSARs are established and how neural networks can be employed in this 
process but also provides a general introduction to neural networks and their training. 
Another review from Walters and Murcko
8
 concentrates on the automated prediction of „drug-
likeness‟, i. e. to select compounds which can be developed into actual drugs from the vast 
combinatorial space of all small molecules. 
Tetko et al
9
 combine the advantages of comparative molecular field analysis (CoMFA) with 
neural networks. CoMFA field variables that describe the 3D structure of the small molecule are 
clustered by a self-organizing map to determine the most relevant descriptors. A neural network 
is trained with back-propagation of errors to predict the activity of each small molecule based on 
the most relevant field variables. 
The QSAR/QSPR models reported in this work are neural networks employing one hidden layer 
with a variable number of inputs and hidden neurons trained with simple back-propagation of 
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error, or resilient propagation
10
. However, the input to the QSAR models (virtual HTS, chapters II 
to IV) consists only of molecular descriptors, while the QSPR model (carbon chemical shift 
prediction, chapter V) only employs atom descriptors derived from the molecular environment of 
each carbon atom of interest. 
Allosteric modulation of metabotropic glutamate receptors 
Metabotropic gluatamate receptors (mGlus) are G-protein coupled receptors divided into eight 
subtypes in three classes
11
. They are connected to a number of disorders of the central nervous 
system like schizophrenia
12, Parkinson‟s disease13, and fragile X syndrome14. Selectively 
targeting specific mGlu subtypes would allow treatment of these diseases without interfering with 
other glutamate receptors, which is believed to reduce adverse effects. Pin et al
15
 gave an 
overview of the overall structure of mGlus, pharmacophore models, allosteric binding sites, and 
available selective ligands for each group of mGlus in 1999. Since then, other modulators for the 
different subgroups have been discovered. Gasparini
12b
 et al specifically describe allosteric 
modulators of group I (mGlu1 and mGlu5) mGlus. For a recent overview on allosteric 
modulation of G-protein coupled receptors and its therapeutic potential, see Conn et al
16
. 
High-throughput screens in drug discovery 
The virtual high-throughput screens described in chapters II and IV are based on the high-
throughput screening data published by Rodriguez et al
3
 in 2010. A local collection of 160,000 
small molecules was screened in a single-concentration triple-add calcium flux assay for 
modulators of mGlu5. Potentiators (2,403) and antagonists (624) were tested in a concentration 
response curve experiment with ten concentrations ranging from 0.1nM to 0.1mM. Sixty percent 
(1,387) of the potentiators and 55% (345) of the antagonists were confirmed. Curves were fitted 
to the concentration responses to determine EC50 and IC50 values. 
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Virtual high-throughput screens 
QSAR/QSPR models can be employed for virtual high-throughput screens, i.e., the search for 
(virtual) molecules with predicted properties in a given acceptance range. These molecules can be 
ordered or synthesized and tested for the desired property. 
In 2001 Harper et al
17
 reported the prediction of biological activities based on binary kernel 
discrimination. Two datasets (1,650 monoamine oxidase inhibitors and 101,437 compounds from 
an enzyme essay) were described by binary descriptors based on atom pairs and topological 
torsions (APTT). Kernel discrimination was compared to merged similarity search and neural 
networks. While it outperformed merged similarity search, neural networks proved a better 
method in some of the experiments, especially since learning rate, momentum, and hidden 
neurons were not optimized leaving room for improvement. 
Jorissen et al
18
 employed support vector machines to virtually screen for 50 inhibitors each of 
different target like cyclooxygenase-2, cyclin-dependent kinase 2, etc. The inactive molecules 
were drawn from the National Cancer Institute diversity set of chemical compounds. The 
chemical descriptors were computed with the DRAGON program based on CORINA 
conformations. Enrichment factors were calculated in the same fashion, as reported in this work. 
While the method outperforms binary kernel discrimination, the data sets are rather small and 
known active compounds were retrieved from a set of unrelated inactive compounds. It is not 
immediately clear if these results will hold in an experiment where external compounds are 
ordered and tested as in the virtual high-throughput experiments described here.    
In 2007 Noeske et al
19
 described a similarity search based on CATS-2D descriptors for finding 
novel allosteric mGlu1 antagonists. After discovering a highly active antagonist based on a 
coumarine scaffold and developing it into a small molecule library, this approach was further 
developed in the 2009 paper
20
 where self-organizing maps were trained on the CATS-2D 
7 
 
description of pharmacologically active molecules in the COBRA collection. A set of 357 known 
allosteric antagonists of mGlu1 was projected onto the trained map to identify neurons connected 
to allosteric mGlu1 antagonists. The actual vHTS consisted in mapping the Asinex Gold 
Collection 2003 (194,563 compounds) onto the trained map and identifying 28 screening 
candidates from the 60 top-ranked compounds. One compound showed activity below 1µM, five 
between 1 and 15µM in an rmGlu1 assay. 
In this work, vHTS for mGlu5 PAMs, NAMs, and mGlu4 PAMs are reported. The trained QSAR 
models were employed to screen commercially available databases (ChemBridge and ChemDiv).  
Positive allosteric modulation of metabotropic glutamate receptor subtype 5 
For a review of the role of positive allosteric modulation of glutamate receptor subtype 5 as a 
treatment strategy for schizophrenia see Conn et al
12a
. This explains the great interest in 
identifying novel positive allosteric modulators of mGlu5 during the last years. Several 
publications present novel PAMs and their function in cooperation with the receptor.  
CPPHA was one of the earlier potent and selective PAMs for mGlu5 reported by O‟Brien et al21. 
It had no agonist activity on its own and acted as a PAM in human and rat mGlu5 assays. Being 
active in both assays strengthens the claim that it works directly on mGlu5. It was an extension of 
earlier work
22
 from the same group describing a whole family of benzaldazines functioning as 
allosteric modulators of mGlu5 including the negative allosteric modulator 3,3′-
dimethoxybenzaldazine with an IC50 of 3µM. 
Kinney et al
23
 described CDPPB as a brain penetrating drug that can reverse amphetamine-
induced locomotor activity and deficits in prepulse inhibition in rats. These animal models can be 
employed to assess antipsychotic drug treatment. It supports the hypothesis that allosteric 
modulation of mGlu5 can assist in developing antipsychotic drugs. 
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Lindsley et al
24
 reported the discovery of the first centrally active allosteric modulators of mGlu5. 
A small molecule library was developed around a set of highly active benzamides. This 
compound class also plays a prominent role in chapter II, since it is one of the larger classes of 
compounds identified by the QSAR model.  
The connection between positive and negative allosteric modulation of mGlu5 is made by Chen et 
al
25
 showing that the PAMs 3,3-difluorobenzaldazine and CDPPB bind to the same site as the 
NAM MPEP. Other PAMs not binding to this site are reported. Eliminating MPEP binding 
through mutation of mGlu5 or binding a neutral ligand to this site reduces or antagonizes positive 
allosteric modulation of the receptor. 
Additional information on positive allosteric modulation of mGlu5 can be found in the 
introduction to chapter II. 
Positive allosteric modulation of metabotropic glutamate receptor subtype 4 
Positive allosteric modulation of mGlu4 is thought of as a possible treatment for Parkinson‟s 
disease. This is based on observations of Valenti
26
 et al that activation of mGlu4 created 
antiparkinsonsian actions in behavioral rodent models via inhibition of transmission at the 
striatopallidal synapse. Furthermore, activation of mGlu4 could have neuroprotective effects by 
reducing the release of glutamate in the substantia nigra
27
. 
Maj et al
28
 showed the neuroprotective effects of (-)-PHCCC against NMDA and β-amyloid 
protein toxicity. They reported (-)-PHCCC before as a positive allosteric modulator of mGlu4.  
Allosteric modulation of human mGlu4 was reported for MPEP and SIB-1893 by Mathiesen et 
al
29
 in 2003. The selectivity of these compounds for mGlu4 can be derived from the fact that 
neither of them had any effect on either mGlu2 expressing cells or the parent cell line. 
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In 2008 Niswender et al
4b
 published data derived from the Vanderbilt high-throughput screen for 
mGlu4 PAMs which was also employed for the work reported in chapter III. A set of 434 mGlu4 
PAMs was identified in the screen. Potencies, maximal glutamate responses, and fold shifts in 
concentration response curves were reported for some of these compounds. Several experiments 
were conducted to establish the selectivity of the novel mGlu4 PAMs with respect to other 
mGlus. The authors point out that the aforementioned MPEP and SIB-1893 are potent mGlu5 
antagonists rendering them unfeasible as selective mGlu4 PAMs. PHCCC works as an mGlu1 
antagonist and has low potency and solubility. The lead compound highlighted in this reference 
(VU0155041) potentiated glutamate at mGlu4 by a factor of eight, is highly selective, and soluble 
in an aqueous vehicle.   
Additional information on positive allosteric modulation of mGlu4 can be found in the 
introduction to chapter III. 
Negative allosteric modulation of metabotropic glutamate receptor subtype 5 
Negative allosteric modulation of metabotropic glutamate receptor subtype 5 has potential in the 
treatment of fragile-x syndrome. For an overview of literature supporting this connection see 
Dölen et al
14
. 
In 1999 Varney et al
30
 employed high-throughput screening to find the first two selective 
antagonists of mGlu5, SIB-1757 and SIB-1893. While showing µM activity at human mGlu5a, 
there was no measurable effect on other mGlu subtypes except a minute agonist activity of SIB-
1893 on mGlu4 (26.4µM). Furthermore, both compounds were inactive for recombinant 
ionotropic glutamate receptors. 
Gasparini et al
31
 modified SIB-1757 and SIB-1893 to generate 2-Methyl-6-(phenylethynyl)-
pyridine (MPEP), a selective mGlu5 NAM with even higher potency (36nM for human mGlu5a). 
No activity was measured for other metabotropic or ionotropic glutamate receptors. Also, MPEP 
10 
 
showed no activity in the absence of agonists. Additional work was carried out to show that 
MPEP acts at a novel pharmacological site of the mGlu5 transmembrane region
32
 and to develop 
it into a mGlu5 selective radioligand
33
. 
Based on the development of MPEP, Yan et al
34
 could suppress two of the symptoms of a fragile 
X syndrome mouse model, sensitivity to audiogenic seizures and the tendency to spend more time 
in the center of an open field. They conclude that this could reduce symptoms of fragile X 
syndrome. 
Rodriguez et al
35
 published two close derivatives of MPEP (Br-5MPEPy and M-5MPEP) which 
are partial antagonists of mGlu5. A third compound (5MPEP) exhibits no effect on mGlu5 on its 
own but blocks both MPEP (NAM) and CDPPB (PAM) from modulating mGlu5. 
In 2009 the same group reported a set of novel mGlu5 NAMs representing scaffolds different 
from MPEP
36
. Three structurally diverse compounds show sub-µM activity towards inhibition of 
mGlu5. One of the NAM leads could also be developed into weak PAMs for the first time in a 
non-MPEP-like ligand.  
Prediction of carbon chemical shift 
Empirical methods for general carbon chemical shift prediction rely on large databases of 
compounds with known chemical shifts. Three options are common to predict chemical shifts for 
a small molecule: i) look up a similar compound with known chemical shifts in the database, ii) 
derive addition rules from known compounds in the database to describe how certain substituents 
and fragments influence the chemical shifts, and iii) train machine learning methods on the 
known chemical shifts. 
Predicted chemical spectra can be employed to distinguish between different structural proposals 
for an unknown compound, assisting with its structure elucidation
37
.  In a similar fashion possible 
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stereoisomers can be filtered to reduce the number of structure verification experiments
38
. 
Another interesting application is the calculation of chemical properties like the natural logarithm 
of the n-octanol/water partition coefficient (logP) based on predicted chemical shifts, molar 
volume, and hydrogen bonds
39
. 
Kalchhauser and Robien
40
 introduced the computer program CSEARCH for prediction and 
automatic assignment of carbon chemical shifts. The original version was based on 8,000 spectra 
from the literature. The chemical shift prediction is based on the HOSE
41
 code with increasing 
number of spheres (1..5). The automatic assignment is based on constructing an isomorphism 
between predicted and experimental chemical shifts. At each level of HOSE code prediction 
experimental shifts are sorted out which can be definitively assigned. The remaining shifts 
constitute a smaller sub-matrix. With increasing level of HOSE code prediction, the number of 
unassigned shifts should go to zero. 
An example of structure elucidation based on addition rules is Tusar et al
42
. Here both proton and 
carbon chemical shifts are predicted as the sum of a basic shift depending on the environment of 
the atom of interest, cross-correlation terms for substituents, and correction terms for 
configuration and conformation which are not described by the first two terms. A structure 
generator creates all possible molecules under given constraints for which chemical spectra are 
predicted. The one closest to the experimental spectrum is selected as the solution. 
The CAST/CNMR system introduced by Satoh et al in 2003
43
 is based on a database combining 
structural information with NMR chemical shift data. The CAST method encodes the 
environment of each carbon atom including stereochemistry. This information allows looking up 
similar atoms in a database of 733 compounds. The predicted shift is the average of all hits found. 
This approach was expanded later to include the size of rings which will influence the chemical 
shifts significantly
44
. The examples show improved chemical shift predictions for several natural 
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products, but again the overall error cannot be assessed. The size of the database doubled, making 
direct comparison of the quality of the predicted shifts difficult. 
Blinov et al
45
 reported a partial least square regression model trained on 2 million chemical shifts. 
The encoding is similar to Bremser
41
 and Meiler
46
. The number of latent variables was optimized 
on approximately 10% of the dataset. The optimal amount is reported as being between 20 and 
70. Furthermore, the optimal number of spheres around the atom of interest was determined to be 
four. Optimization of carbon atom types for the atom of interest led to eleven classes based on 
hybridization, number of hydrogen atoms attached, and participation in an aromatic system. To 
further improve the predictions cross-correlation terms between all atoms in the first three spheres 
around the atom of interest which were not more than three bonds apart from each other were 
introduced. This lowered the      between actual and predicted chemical shifts to 2.76ppm 
(average deviation 1.85ppm). 
The focus of this work is to utilize machine learning to establish quantitative structure-activity or 
structure-property relationships. These trained models were successfully employed to identify 
positive allosteric modulators of metabotropic glutamate receptor subtypes 4 (chapter III) and 5 
(chapter II), negative allosteric modulators of subtype 5 (chapter IV), and to predict carbon 
chemical shifts (chapter V). 
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CHAPTER II 
IDENTIFICATION OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 
POTENTIATORS USING VIRTUAL HIGH-THROUGHPUT SCREENING 
Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; 
Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; 
Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using 
Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 
American Chemical Society. 
Introduction 
Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system 
(CNS) and activates metabotropic glutamate receptors (mGlus), which are coupled to downstream 
effector systems through guanine nucleotide binding proteins (G proteins)
47
. The mGlus provide a 
mechanism by which glutamate can modulate or fine tune activity at the same synapses on which 
it elicits fast synaptic responses. Because of the wide diversity, heterogeneous distribution, and 
diverse physiological roles of mGlu subtypes, the opportunity exists for developing therapeutic 
agents that selectively interact with mGlus involved in only one or a limited number of CNS 
functions. Such drugs could have a dramatic impact on development of novel treatment strategies 
for a variety of psychiatric and neurological disorders including depression
48
, anxiety disorders
49
, 
schizophrenia
12a, 50
 , chronic pain
51
, epilepsy
52, Alzheimer‟s disease53, and Parkinson‟s disease54. 
The mGlu5 receptor subtype is a closely associated signaling partner of the ionotropic N-Methyl 
D-Aspartate receptor (NMDAR) and may play a significant role in setting the tone of NMDAR 
function in forebrain regions containing neuronal circuits important for cognitive behavior and for 
reporting on efficacy of antipsychotic agents
50c
. 
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Activators of mGlu5 may provide a novel approach to treatment of schizophrenia  
Activation of mGlu5 potentiates NMDAR function in forebrain circuits thought to be disrupted in 
schizophrenia. The mGlu5 selective allosteric antagonist 2-methyl-6-(phenylethynyl)-pyridine 
(MPEP) potentiates the effect of the non-competitive NMDAR antagonist phencyclidine (PCP) in 
behavioral phenotypic assays
55
 and mGlu5 knockout mice have deficits in pre-pulse inhibition in 
acoustic startle response behavioral assays compared with wild-type mice
55c, 56
. Positive allosteric 
modulators of mGlu5 have recently been developed and reported
21-24, 57
. Four well-characterized 
structural classes of mGlu5 allosteric potentiators have been identified, including benzaldazine 
derivatives [3,3-difluorobenzaldazine] (DFB), two types of benzamides, [N-{4-chloro-2-[(1,3-
dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide] (CPPHA) and [3-
cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide] (CDPPB), and an oxadiazole chemotype 
represented by ADX-47273
58
. Despite striking functional similarities, radioligand binding studies 
revealed different mGlu5 binding profiles for DFB and CDPPB compared with CPPHA
21, 23, 59
. 
Both CDPPB
23-24
 and ADX-47273
58a, b, 58d
 have displayed in vivo efficacy in behavioral models. 
Unfortunately, lead optimization of the CDPPB scaffold was unable to address a number of issues 
including poor physiochemical properties due to lack of solubility in many vehicles
57
. However, 
some improvement of physicochemical properties was recently reported for the mGlu5 ago-
potentiator ADX-47273
58c
. Recent reports have also shown that small structural modifications to 
related compounds in a series including benzaldazine and (phenethynyl)pyrimidine scaffolds can 
bind to a single allosteric site to exert effects ranging from partial to full antagonism to positive 
allosteric modulation
22, 60
. For these reasons, further validation of mGlu5 potentiation as a 
therapeutic approach to Schizophrenia requires the discovery of novel chemotypes possessing 
improved physiochemical and pharmacological properties.  
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High-throughput screening in drug discovery 
High-throughput screening (HTS) is the process of testing a large number of diverse chemical 
structures against potential disease targets to identify new potential lead compounds by taking a 
rapid, high efficiency approach to generation of ligand-target interaction datasets
61
. More than 
120 GPCR-based HTS assays have been published in PubChem (pubchem.ncbi.nlm.nih.gov). For 
example, 63,676 compounds were screened at Vanderbilt in an assay for allosteric agonist 
activity at acetylcholine Muscarinic M1 Receptor to identify 309 confirmed M1 agonists 
(PubChem Bioassay number AID626 (primary screen) and AID1488 (confirmatory screen)). 
Increased GPCR screening capabilities featuring enhanced sample handling and increased 
throughput via miniaturization up to 1,536 well format have recently been reported for targets 
such as M1 acetylcholine receptor
62
 and 5HT2b serotonin receptor
63
. However, current literature 
suggests that one marketable drug emerges from the information gained by screening 
approximately one million compounds
61a
. If fewer compounds could be tested without 
compromising the probability of success, library purchasing cost and screening time as well as 
failure rates in clinical testing may be reduced
61, 64
. 
Quantitative structure activity relations in drug discovery 
Quantitative structure activity relations (QSAR) attempt to model complex non-linear 
relationships between the chemical and physical properties of molecules and their biological 
activity (reviews
65
). Hansch et al. established classical QSAR analysis as a paradigm by reporting 
the use of Hammett substituent constants to establish a quantitative relation between electron 
density and biological activity
66
. At the same time, they introduced a new hydrophobic parameter, 
the partition coefficient (P) of the compound in a 1-octanol-water system (logP). Variations and 
extensions of Hansch‟s analysis have been applied to drug discovery for over 40 years and rely on 
well-studied scalar or 2D descriptors such as calculated logP (cLogP), molecular refractivity 
(CMR), and Topological Polar Surface Area (TPSA). Modern QSAR techniques employ 
16 
 
advanced 2D molecular fingerprints and 3D molecular descriptors coupled with machine 
learning
7, 67
. High-resolution methods such as Comparative Molecular Field Analysis (CoMFA)
68
 
and Comparative Molecular Similarity Indices Analysis (COMSIA)
69
 require the alignment of 
biologically relevant 3D conformations of molecules with a common substructure to generate a 
map of regions important for the structure activity profile of a given related series of molecules. 
Numerical descriptors of chemical structure for QSARs 
Encoding schemes that are “fragment-based” usually identify a common fragment in small 
focused chemical libraries and chemical modifications to that fragment (common substructure) 
are numerically encoded (size of a substituent in position A, presence of a negatively charged 
group in position B, atom type in heterocyle C, etc.). Examples of fragment-based strategies 
include MACCS
70
, binary structural keys based on occurrence/counts of up to 166 different 
chemical features found in a compound; HQSAR
71
, a 2D method for capturing chiral information 
based on a Molecular Hologram hashing algorithm without the requirement for generation of 3D 
coordinates; and SKEYS/FRED, a combination of MDL structural key based fingerprints with an 
evolutionary algorithm
72
.  
Traditional 2D- and 3D-QSAR methods often require fragment-based structural encoding 
schemes
70b, 73
 or conformational superposition of biologically active conformations of the 
chemical structures
68b, 74
 that may restrict the utility of resulting models to predictions related to 
single chemotypes
73
 or single protein binding sites
73, 74b
. While suitable for optimization of a lead 
structure in a small focused library, such encoding schemes often preclude analysis of large, 
diverse databases as the large majority of the substances in such a database will not share a large 
common fragment. 
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Fragment-independent transformation-invariant descriptor schemes 
Fragment-independent molecular descriptors have the potential to encode a large diversity of 
chemical scaffold information into mathematical representations not sensitive to scaffold size, 
composition, and rotation/translation of 3D coordinate molecule representations. Use of feature 
point pharmacophores (FEPOPS), an automated method that simplifies flexible 3D chemical 
descriptions, was recently reported to outperform traditional 2D- and 3D-QSAR methods for 
enrichment of actives taken from high-throughput screening compound collections
74b
 and to 
identify novel chemotypes with biological activity at query targets from virtual screens
75. A 
recent study of HIV-1 integrase inhibitors introduced atom-type linear indices of the molecular 
pseudograph atom adjacency matrix as fragment-independent indices containing important 
structural information to be used in QSAR and drug design studies
76
. Radial distribution functions 
have recently been shown to outperform traditional fragment-based molecular descriptors in a 
study of the chick intestinal Vitamin D receptor affinity of 49 Vitamin D analogues
77
 and in an 
investigation to separate the activity of carcinogenic and non-carcinogenic compounds in a rodent 
toxicity model
78
. Autocorrelation functions are fragment independent, invariant to translation and 
rotation, and encode identity and electronic attributes of molecular structure including atom types, 
partial atomic charges, electronegativity and polarizability into vector representations5b. Several 
studies have employed autocorrelation descriptors for training machine learning algorithms for 
applications including separation of dopamine agonists and benzodiazepine receptor agonists
79
, 
virtual screening for chemical library enumeration
80
, and identification of novel chemotypes
81
. 
Surface area correlation functions store molecular shape geometry for molecules with known 
biological activity into neural networks for shape-based molecular recognition in external 
datasets, as reported for the analysis of corticosteroid-binding globulin activity of steroids
82
. Self-
organizing neural networks using molecular electrostatic potential as the structural encoding 
scheme were also successfully applied to study structurally different classes of muscarinic 
acetylcholine receptor allosteric modulators
83
.  
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Application of machine learning algorithms to establish QSARs 
Machine Learning algorithms have proven to be of practical value for approximating non-linear 
separable data, especially for classifying biological target data
67b, 84
. Recently, a machine learning 
approach was applied to generate a model for the tubulin polymerization activities of a library of 
250 analogs of the anti-cancer drug Epothilone
67a
. ANNs have been successfully applied for many 
years in chemistry and biochemistry to generate QSAR models
7,85,86
. Studies were reported 
involving prediction of dihydrofolate reductase inhibition based on data derived from high-
throughput screening using pre-clustering and evolved neural networks
87
 as well as applications 
for  prescreening compounds for HIV inhibition while optimizing specificity and potency
88
. Our 
group recently published a theoretical comparison of machine learning techniques for 
identification of compounds that are predicted allosteric modulators of the mGlu5 glutamate 
response
89
.   
Quantitative structure activity relation models for mGlu5 positive allosteric modulation  
The objective of the present research is to employ ANNs to develop QSAR models for mGlu5 
PAM activity. QSAR models capable of combining the structural diversity of different chemical 
scaffolds into a single model could inform the discovery of new chemotypes for allosteric 
potentiation of the mGlu5 glutamate response.  Such models may also be useful for identification 
of compounds with a spectrum of activity (agonists, antagonists, and allosteric potentiators) by 
analogy to the well-documented activities of agonists, inverse agonists and neutral antagonists at 
orthosteric binding sites on a broad range of receptors
22, 35, 60
. Activity data for mGlu5 PAMs 
obtained from a high-throughput screen of ~150,000 compounds is used to develop the QSAR 
model. A set of fragment independent and transformation invariant chemical descriptors serves as 
input for the ANN. A novel strategy for selection of an optimal descriptor subset yields QSAR 
models that enrich active compounds by a factor of up to 38 in independent datasets. The method 
is applied to a virtual screen of a commercial library of ~450,000 available compounds. A set of 
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824 compounds with predicted mGlu5 PAM activity containing multiple chemical scaffolds was 
experimentally tested. 
Results and Discussion 
 
Machine learning techniques were applied to generate specific QSAR models for allosteric 
potentiation of the mGlu5 glutamate response. These models were then used to prioritize 
compounds for acquisition with the aim of enhancing both the speed and diversity of hit-to-lead 
discovery efforts for mGlu5 positive allosteric modulators (PAMs).  
Discussion of concentration response curves in the experimental high-throughput screen 
Concentration response curves were generated from the averaged data of three experiments using 
a four point logistical equation,   
 
   
 
 
  
.  No parameters were constrained and no values were 
weighted.  Points corresponding to concentrations of PAM exhibiting an agonist effect were 
excluded from the analysis.  For a PAM with excellent potency (EC50 value below 100 nM), 95% 
confidence intervals were on average within a range of 30 nM.  For a PAM with moderate 
potency (EC50 value roughly 100 nM to 1 µM), confidence intervals were within a range of 300 
nM.  For a PAM with low potency (EC50 value above 1 µM), 95% confidence intervals were 
generally within a range of 1.5 µM.  Weak PAMs whose concentration response curve did not 
reach a plateau but did significantly enhance a glutamate EC20 were categorized as PAMs but fit 
statistics were not determined. A summary of fit statistics and a concentration response curve for 
one example of each of the major scaffolds identified including benzoxazepine, phenylethynl-
phenyl, and benzamide PAMs is detailed in Table 1 and Figure 1. 
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Table 1: Summary of fit statistics for one example of each of the major scaffolds identified 
using a virtual high-throughput screen. Reprinted with permission from Mueller, R.; Rodriguez, 
A. L.; Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, 
C. D.; Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of Metabotropic Glutamate Receptor 
Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 
(4), 288-305. Copyright 2010 American Chemical Society. 
  95% Confidence Limit  
Scaffold IC50 (nM) Upper Limit (nM) Lower Limit (nM) r
2
 
Phenylethynyl-phenyl 28.0 43.1 12.8 0.99 
Benzamide 344 382 306 0.99 
Benzoxazepine 4120 4650 3590 0.99 
 
 
Figure 1: Concentration response curves for (A) phenylethynyl-phenyl, (B) benzamide, and 
(C) benzoxazepine PAMs. Solid circles indicate individual data points. Solid lines indicate fit 
derived from averaged data. Dotted lines indicate 95% confidence limits. Points within squares 
were excluded from analysis due to agonist activity. Reprinted with permission from Mueller, R.; 
Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, 
A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of Metabotropic 
Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS 
Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 American Chemical Society. 
Input sensitivity is a reliable measure to prioritize descriptors 
The selection of input descriptors with highest input sensitivity reduces the degrees of freedom 
within the ANN model and results in models with substantially improved prediction capability. 
The input sensitivity can be understood as the partial derivative of each input with respect to the 
output of the ANN (see Methods). The main reason for this improvement is reduction of noise 
B C A 
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through the increased ratio of datasets versus weights. An increased ratio of datasets versus 
weights leads to more information available to fit every degree of freedom. Each degree of 
freedom can be determined more precisely despite the intrinsic noise of HTS data used for 
training. Since several of the ADRIANA molecular descriptors (see Methods) encode the same 
chemical property with different encoding functions, it seems plausible that information in these 
descriptors is redundant and therefore doesn‟t add to the determination of the optimal solution. 
Optimization of molecular descriptor set improves prediction accuracy of the ANN model 
To obtain a baseline for descriptor optimization, an ANN was trained using only the scalar 
descriptors 1-8 (Table 2). The root mean square deviation        see Equation 1) value for the 
independent data set of 0.228, area under the receiver operating characteristic curve       value 
of 0.673 and                                                               value of 6 
served as a basis for comparison in model optimization (Table 3). For a detailed discussion of 
these measures see Methods. The individual sensitivity value for „XlogP‟ (0.97) remained the 
highest in the baseline network with the remaining input sensitivity distributed across the other 
scalar descriptors (Figure 2a). Keeping the scalar descriptors in the following models allowed 
comparing their sensitivity with this baseline. 
Equation 1: 
     √
∑              
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Figure 2: Schematic view of an ANN: a) Up to 1,252 descriptors (from 35 categories) are fed 
into the ANN input layer. b) The weighted sum of the input data is modified by the activation 
function and serves as input to the next layer. c) The output predicts the biological activity of the 
input molecule based on complex non-linear relationships derived from machine learning through 
iterative ANN model training. Panel (a) displays input sensitivities for iterations 1-6 as a heat 
map from least sensitive (red) to most sensitive (green). The final optimized ANN model with 
276 descriptors is highlighted by a black frame. Reprinted with permission from Mueller, R.; 
Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, 
A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of Metabotropic 
Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS 
Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 American Chemical Society. 
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Table 2: Summary of 1,252 molecular descriptors in 35 categories computed with ADRIANA. 
Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; 
Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; 
Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using 
Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 
American Chemical Society.  
 Description Method Description Property Abbreviation Number 
1 Scalar descriptors Molecular weight of compound Weight 1 
2  Number of hydrogen bonding acceptors HDon 1 
3  Number of hydrogen bonding donors HAcc 1 
4  
Octanol/water partition coefficient in [log 
units] 
XlogP 1 
5  Topological polar surface area in [Å
2
] TPSA 1 
6  Mean molecular polarizability in [Å
3
] Polariz 1 
7  Dipole moment in [Debye] Dipol 1 
8  
Solubility of the molecule in water in [log 
units] 
LogS 1 
9 2D Autocorrelation atom identities 2DA_Ident 11 
10  σ atom charges 2DA_SigChg 11 
11  π atom charges 2DA_PiChg 11 
12  total charges 2DA_TotChg 11 
13  σ atom electronegativities 2DA_SigEN 11 
14  π atom electronegativities 2DA_PiEN 11 
15  lone pair electronegativities 2DA_LpEN 11 
16  effective atom polarizabilities 2DA_Polariz 11 
17 3D Autocorrelation atom identities 3DA_Ident 12 
18  σ atom charges 3DA_SigChg 12 
19  π atom charges 3DA_PiChg 12 
20  total charges 3DA_TotChg 12 
21  σ atom electronegativities 3DA_SigEN 12 
22  π atom electronegativities 3DA_PiEN 12 
23  lone pair electronegativities 3DA_LpEN 12 
24  effective atom polarizabilities 3DA_Polariz 12 
25 
Radial Distribution 
Function 
atom identities RDF_Ident 128 
26  σ atom charges RDF_SigChg 128 
27  π atom charges RDF_PiChg 128 
28  total charges RDF_TotChg 128 
29  σ atom electronegativities RDF_SigEN 128 
30  π atom electronegativities RDF_PiEN 128 
31  lone pair electronegativities RDF_LpEN 128 
32  effective atom polarizabilities RDF_Polariz 128 
33 Surface Autocorrelation molecular electrostatic potential Surf_ESP 12 
34  hydrogen bonding potential Surf_HBP 12 
35  hydrophobicity potential Surf_HPP 12 
 Total 1252 
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Table 3: The     ,    , and            values for all mGlu5 PAMs QSAR models.  
Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; 
Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; 
Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using 
Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 
American Chemical Society. 
 
Iteration Number and type                        
 of descriptors train monitor independent   
all 1252 1-35 0.196 0.248 0.248 0.701 10 
scalar 8 1-8 0.223 0.224 0.228 0.673 6 
1 428 
1 – 8, 23, 
30–32, 34, 
35 
0.196 0.212 0.214 0.731 36 
2 416 
1–8, 23, 30–
32, 34 
0.193 0.213 0.216 0.742 38 
3 404 
1–8, 23, 30–
32 
0.191 0.214 0.214 0.731 36 
4 276 
1–8, 23, 30, 
31 
 0.185  0.215 0.212 0.757 38 
5 148 1–8, 23, 31 0.203 0.215 0.217 0.738 25 
6 136 1–8, 31 0.204 0.214 0.217 0.742 25 
Method       
Binary 276 1-35 0.334 0.370 0.385 0.744 26 
 
Undersampled: 
      
-Random 276 
1–8, 23, 30, 
31 
0.202 0.226 0.221 0.757 8 
-MACCS 276 
1–8, 23, 30, 
31 
0.171 0.195 0.217 0.654 2 
 
 
The most sensitive 428 descriptors in 14 categories were retained for additional iterations of 
descriptor optimization. Retraining of the ANN with 428 descriptors (iteration 1) yields 
significantly improved metrics relative to the baseline model (scalar only) including an      
value for the independent data of 0.214, an     value of 0.731 and an            of 36 (Table 
3). To further optimize the set of descriptors, the least sensitive descriptor categories were 
systematically removed in an iterative process (Table 3 iterations 2-6; Figure 2a). In particular, 
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the enrichment measure is substantially improved with respect to the scalar only baseline ANN as 
emphasized by the initial slope of the ROC curves in Figure 3. 
 
Figure 3: Receiver Operating Characteristic (ROC) curve plot: Traditional (8) scalar QSAR 
descriptors (HTS_8, dotted grey line) were compared to groups of ADRIANA scalar and vector 
descriptor sets from the input sensitivity analysis (see Figure 2a) by plotting ROC curves to 
examine the initial slope. The descriptor set was systematically reduced in size in sequential steps 
using oversampled data from HTS_428 to HTS_8 to statistically optimize the final QSAR model 
of the mGlu5 experimental HTS dataset. Based on the ROC curve analysis, HTS_276 descriptors 
(heavy black line) and HTS_428 descriptors (heavy grey line) displayed the best signal to noise 
profiles. Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; 
Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. 
W.; Conn, P. J.; Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 
Potentiators Using Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-
305. Copyright 2010 American Chemical Society. 
 
Iterations 1-4 remove 152 descriptors to yield a set of 276 descriptors including the eight scalar 
descriptors, the 3D auto-correlation lone pair electronegativity, and the radial distribution 
functions for lone pair electronegativity and π-electronegativity (Table 3; Figure 2a). Retraining 
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of the ANN with 276 descriptors yields a      value for the independent data of 0.212, an     
value of 0.757 and an            of 38.  
In the last two iterations 5 and 6, the radial distribution function for π-electronegativity and the 
3D autocorrelation function for lone-pair electronegativity were removed (Figure 2a; Figure 3). In 
iteration 5, the ANN with 148 descriptors failed to improve the model as indicated by an      
value for the independent data of 0.217,     value of 0.738 and an            of 25 (Table 3).  
In iteration 6, the ANN with 136 descriptors had similar quality measures. 
At this point, the iterative descriptor optimization procedure was terminated. The ANN model 
from iteration 4 with 276 input descriptors is considered to be the optimal model as it displays 
optimal performance on the independent dataset combined with the smallest descriptor set. This 
network was used in all in silico screening experiments described below.  
The rationale for keeping the scalar descriptors with lower sensitivity throughout descriptor 
optimization is to maintain comparability with the baseline established by training with these 
eight descriptors alone (read below). These parameters relate to „Lipinski‟s Rule of Five‟90 and 
therefore widely accepted criteria for drug-like compounds. Note that the scalar descriptors 
represent only 0.6% of all descriptors. Removal of scalar descriptors will therefore not decrease 
the complexity of the ANN model.  
Balancing the datasets through oversampling yields better results than two undersampling 
strategies 
The oversampling strategy employed throughout the study was compared with two approaches 
that undersample inactive compounds when using the optimized 276 input descriptors (see 
Methods, Figure 4). Usage of randomly chosen inactive compounds resulted in a      value for 
the independent data of 0.221,     value of 0.753 and an            of 8. Determining inactive 
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compounds for undersampling maximally similar to the active compounds yields in an      
value for the independent data of 0.261,     value of 0.654 and an            of 2 (Table 3). 
 
 
Figure 4: Receiver Operating Characteristic (ROC) curve plots for undersampling methods 
comparison: ROC curve analysis showing optimized descriptor set HTS_276 based on 
oversampling (solid black line) compared to undersampling using a random selection of inactive 
compounds for monitoring and training dataset (solid grey line) as well as a selection of most 
similar inactive to active compounds (dashed grey line). Reprinted with permission from Mueller, 
R.; Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; 
Bleckmann, A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of 
Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput 
Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 American Chemical 
Society. 
 
Our interpretation of this finding is that our models do not so much recognize active compounds 
but rather filter out inactive compounds. Hence detailed knowledge of the entire space of inactive 
compounds improves performance of the models in binary classification settings. Random 
selection of a small fraction of inactive compounds reduces the space of inactive compounds 
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substantially; targeted selection of inactive compounds similar to active compounds reduces the 
space even more. The model loses the ability to classify molecules dissimilar from active 
compounds. 
Radial distribution functions and electronegativity contribute most to an accurate prediction 
Analysis of input sensitivity by encoding functions (3D Autocorrelation, Radial Distribution 
Functions, Surface Autocorrelation) reveals superior performance of radial distribution functions 
across the six ANN  models tested (Figure 2a). Surface Autocorrelation functions were only 
tested in the first two models (428 and 416 descriptors) due to lower sensitivity scores (Figure 
2a). Analysis of input sensitivity by property revealed high sensitivities for π atom (0.92-1.38) 
electronegativity, lone pair (1.42-2.54) electronegativity, and for polarizability (0.70-0.94). 
The impact of these descriptors makes intuitive sense as active compounds such as 
benzoxazepines and benzamides (Figure 5) that are well represented in the training dataset 
contain extended π conjugated systems as well as hetero atoms with lone pair electrons. However, 
we expect overlap in the description of chemical structure by various groups of descriptors. 
Hence, while the current descriptor set is optimal for prediction of mGlu5 PAM activity, other 
suitable combinations of descriptors can yield similarly good results as demonstrated in iterations 
1, 2, and 3. Nevertheless, descriptor optimization is important as usage of the maximum number 
of descriptors or usage of a small set of scalar descriptors will hamper performance of the QSAR 
model (Table 3; Figure 2a). 
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Figure 5: Scaffold category analysis: I) 1,382 mGlu5 PAMs from HTS were clustered with the 
Mathematica package using the Tanimoto coefficient of the largest common substructure as 
distance measure. Three major scaffolds are constituted by 137 benzoxazepines (9.9%, a), 14 
phenylethynyls (1.0%, b), and 267 benzamides (19.3%, c). II) Scaffold composition of active 
compounds in post-screen. III) Scaffold composition of inactive compounds in post-screen. 
Compounds d), e) and f) are non-trivial mGlu5 PAM scaffold modifications identified by the 
virtual screen using the ANN QSAR model. Panel g) highlights representative compounds found 
inactive in the post-screen. Reprinted with permission from Mueller, R.; Rodriguez, A. L.; 
Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; 
Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of Metabotropic Glutamate Receptor 
Subtype 5 Potentiators Using Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 
(4), 288-305. Copyright 2010 American Chemical Society. 
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A recent study demonstrated the necessity for optimizing molecular descriptor types for each 
individual dataset to yield optimal QSAR models
91
. Other studies independently reported the 
radial distribution function as most robust molecular descriptor category in capturing the structure 
activity signal from experimental HTS datasets
77-78
.  
Virtual screening of ChemBridge compound library  
The ANN QSAR model was applied in a virtual screen of the ChemBridge database of 
commercially available compounds. In silico screening of the entire library of ~450,000 
compounds took approximately one hour on a regular personal computer. A total of 813 
compounds with predicted      values below 1.0 M for mGlu5 PAM activity were selected. An 
additional 11 compounds were chosen based on visual inspection by an expert medicinal chemist 
(C.W.L.) from clusters at a lower potency cutoff of 10 M for a total of 824 compounds. 
The compounds identified in the virtual screen were ordered from the vendor (ChemBridge) and 
tested at the Vanderbilt HTS facility. In an initial primary screen (see Methods) of the predicted 
compound collection from our virtual screen, 260 compounds were identified and classified as 
210 PAMs, 49 partial agonists, and one antagonist. Follow-up CRC assays confirmed 232 
compounds with various activities at mGlu5. The compounds were classified as pure potentiators 
(177), and partial agonists (55). The remaining 27 compounds were either inactive (21, see Figure 
5g), fluorescent (2) or showed increased baseline measurements in the fluorescent assays (4). 
This result reflects an                  ⁄              ⁄     relative to the initial 
experimental HTS hit rate. The experimental enrichment is consistent with the enrichment values 
predicted from analysis of an independent dataset during development of the QSAR model (Table 
3).  
To assess whether the active compounds identified by the present virtual screening approach 
could have been identified through simpler procedures, a similarity search was performed on the 
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ChemBridge database using MACCS structural keys as molecular fingerprints. Implementation of 
a Tanimoto coefficient cutoff of 99 % for similarity between known actives from the high-
throughput screen and compounds with unknown activity yielded a total of 1204 novel hits 
including 849 benzamides, 91 benzoxazepines, and two phenylethynyl-phenyls. The overlap 
between this set and the 232 active compounds identified by the ANN approach is 74 compounds 
(32%). This result demonstrates that our method identified 158 compounds that would have been 
missed in a naïve similarity search. 
Analysis of the newly identified set of mGlu5 potentiators 
According to MACCS fingerprint-based clustering
92
 using a Tanimoto coefficient
92b
 of 0.75 for 
similarity, of the 232 compounds with confirmed mGlu5 activity identified in our virtual screen 
of the ChemBridge commercial library: 67 compounds (28.9%) were classified as 
benzoxazepines with pure potentiator activity (Figure 5a); 2 compounds (0.9%) were structurally 
similar to MPEP (containing a phenylethynyl-phenyl moiety) and displayed partial agonist 
activity (Figure 5b); 53 compounds (22.8%) were classified as benzamide derivatives with partial 
agonist activity and 107 compounds (46.1%) from the same scaffold were classified with pure 
potentiator activity (Figure 5c); and 3 compounds (1.3%) contained other non-trivial scaffold 
modifications (Figure 5d-f) with weaker potentiator activity (          ). The latter 3 
compounds were contained in the 813 compounds predicted at the higher potency (1.0 M 
cutoff).  
Major scaffolds are evenly distributed throughout training, monitoring, and independent datasets 
The library of 1,382 compounds identified as active in the original HTS screen was analyzed 
using a clustering approach. At a cutoff of 25 % similarity, 25 different scaffolds were identified 
(see Methods, Figure 5).  
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All large scaffold clusters were equally represented throughout the training, monitoring, and 
independent data sets. Of the 267 compounds classified as benzamides 214 compounds (80.1%), 
21 compounds (7.9%), and 32 compounds (12.0%) were found in the training, monitoring, and 
independent data sets, respectively;  137 compounds were classified as benzoxazepines, with 114 
compounds (83.2%) in the training set, 13 compounds (9.5%) monitoring set, and ten compounds 
(7.3%) in the independent set;  and lastly, the mGlu5 PAM library contained 14 compounds 
structurally similar to MPEP (containing a phenylethynyl-phenyl moiety), and distributed 
throughout the data sets as followed: twelve compounds (85.7%), one compound (7.1%), and one 
compound (7.1%). 
The majority of hit compounds share a scaffold with previously identified potentiator compounds 
The majority of the compounds recovered contained chemotypes that were the major component 
of the training datasets (Figure 5a-c). Therefore, our results demonstrate a powerful method for 
“hit explosion”, the enumeration of compounds around scaffolds from a HTS experiment. The 
results build a detailed picture of structure-activity relation for each of the scaffolds. In the early 
stages of drug discovery, time can be saved through acquisition of commercially available 
compounds to enumerate focused libraries around confirmed HTS hit compounds. The results can 
help planning of synthetic chemistry efforts. 
Benzamides, benzoxazepines, and MPEP-like compounds are enriched among active compounds 
in the post-screen 
The post-screen library of 824 compounds identified 232 compounds with potentiating activity; 
compounds were analyzed with a clustering approach and yielded five unique scaffolds at a cutoff 
of 25% similarity (Figure 5).  The majority of benzoxazepine and benzamide derivatives form a 
single cluster at this cutoff containing 125 and 66 compounds, respectively. The non-trivial 
scaffold modifications with mGlu5 PAM activity were found in two separate clusters. Each non-
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trivial scaffold modification was observed once in the post-screen library. One cluster consisted 
of the only two MPEP-derivatives found in the active compounds. Note that while benzamides, 
benzoxazepines, and MPEP-like compounds made up only 30% of active compounds in the 
original HTS experiment, 99% of all active compounds identified in the post-screen belong to one 
of these three substance classes. We conclude that the machine learning method excelled in 
recognizing these three scaffolds while other active compounds might have been predicted only at 
a reduced potency cutoff. 
Inactive compounds in the post-screen library contain 53 % benzamides, benzoxazepines, and 
MPEP-like compounds 
The remainder of the post-screen library was shown to be inactive towards the receptor, and a 
clustering approach was utilized to identify 18 unique scaffolds at a cutoff of 25% similarity. The 
major scaffolds seen throughout the training sets (Figure 5a-c) distributed as follows: 24 
compounds were identified as benzoxazepines, benzamide derivatives yielded 278 compounds, 
and 10 compounds structurally similar to MPEP were observed in the compounds confirmed with 
inactivity towards mGlu5. Derivatives of the non-trivial compounds (Figure 5d-f) were 
represented among the inactive compounds five times. We conclude that by far not all 
benzamides, benzoxazepines, and MPEP-like compounds are active PAMs of mGlu5. While the 
ANN enriches for these scaffolds it also collects a number of inactive compounds that share this 
chemotype. In fact, in our original HTS screen a total of 42,588 compounds with these scaffolds 
were found inactive and only 418 were found active which mirrors our overall rate of active 
compounds (0.97 %). In the post-screen library we find 229 derivatives of these scaffolds with 
activity and 312 without. The enrichment of active compounds that share one of these scaffolds is 
44 and therefore somewhat higher than the overall enrichment observed. Note that a naïve 
similarity search for these scaffolds would have failed to produce these enrichment rates and 
therefore the rate of active compounds would have been lower. 
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Significant numbers of hit compounds are non-trivial modifications of original HTS screen hits   
While 99% of the newly identified mGlu5 PAM compounds have a scaffold that has been 
previously identified, only 72% of the 232 compounds were trivial derivatives - i.e. have a single 
functional group added or removed (Figure 5a-c). The remaining 28% had multiple modifications 
with respect to any of the hit compounds in the original HTS screen (Figure 5d-f). These 
compounds would have been difficult to identify with a similarity search as discussed above.  
High potency cutoff may introduce bias to close derivatives of original HTS screen hit compounds  
As part of our virtual screen, several different potency cutoffs (300nM, 1M, 2M, 5M, 10M) 
were employed to identify a compound library size that was tractable for experimental ordering 
and testing. Selection of a predicted potency cutoff of 1.0M for mGlu5 PAM activity might have 
biased the majority of the 824 compounds towards molecules with similar chemotypes to the 
compound classes that represented the majority of the known active compounds included in our 
training dataset (benzoxazepines, phenyl ethynyls and benzamide-containing scaffolds) (Figure 
5a-c). However, with the identification of three non-trivial modifications of known chemotypes 
having mGlu5 PAM activity (     > 2.5 M), “scaffold hopping” appears to be possible using 
this method (Figure 5d-f). The identification of 158 compounds missed by a naïve similarity 
search demonstrates the complementary chemical space sampled in a “hit explosion” setup. For 
this purpose, more compounds should be selected from a lower potency cutoff (10-30M) 
combined with filters to remove compounds with similar chemotypes to those in the training 
dataset. We would expect substantially reduced enrichment factors in such a scenario. We 
included 11 compounds in the 824 compounds ordered from several chemotypes that were 
identified from a cluster analysis of our mGlu5 virtual screen at a lower potency cutoff (10M). 
This small subset of compounds was chosen by visual inspection. We did not discover mGlu5 
PAM activity in any of these compounds. The compounds were either fluorescent or inactive in 
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our experiments. However, this result is inconclusive due to the very small number of compounds 
selected according to these criteria. 
Fragment-independent numerical description deals efficiently with multiple scaffolds 
The observation of three non-trivial chemotype modifications underscores the ability of fragment-
independent numerical descriptions to map chemical structure of a diverse compound library into 
a numerical fingerprint. Different classes of compounds displaying mGlu5 PAM activity 
(phenylethynyls, benzoxazepines, benzamides, etc.) were used in training the ANN models and 
all of those same classes of compounds are recovered in the library of 232 hit compounds. This 
underlines the ability of our machine learning based QSAR model to efficiently deal with 
biologically complex and little understood phenomena in a “black-box”-like fashion.   
Conclusions 
In conclusion, machine learning methods (ANN) were used to generate QSAR models from an 
HTS experimental dataset in virtual screens of an external commercial compound collection for 
the purpose of enrichment of our local library for compounds with mGlu5 allosteric activity. A 
combination of 2D- and 3D- molecular descriptors spanning 35 categories was implemented to 
encode a broad range of physical and chemical data for each compound. Optimization of the 
molecular descriptors used to encode chemical structures minimized noise by excluding less 
sensitive descriptors from training inputs to maximize signal for mGlu5 and proved to be a 
crucial step for increasing enrichment for active compounds. Oversampling of actives was 
included in dataset generation to balance the training of our models and an independent dataset 
representing a randomly selected 10% of the experimental HTS data was reserved for model 
cross-validation purposes. Fragment-independent numerical description deals efficiently with 
multiple scaffolds and (potentially) multiple allosteric sites at the mGlu5 receptor. Model validity 
was assessed based on multiple measures including      between predicted and experimental 
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activity, enrichment of active compounds in a virtually screened compound library, and     
value of ROC curves. The enrichment factor of 30 determined from biological testing of 824 
compounds prioritized from a library of ~450,000 substances demonstrates the predictive power 
of the method. This enrichment factor also agrees with the theoretically predicted enrichment of 
38. While the majority of hit compounds share a chemical scaffold with previously identified 
mGlu5 PAM compounds, a significant fraction of these compounds are non-trivial modifications 
of hit compounds in the original HTS screen. The high potency cutoff used in the virtual screen 
might have introduced the bias to close derivatives of hit compounds in the original HTS screen. 
To attempt identification of novel scaffolds (“scaffold hopping”), lower potency cutoffs should be 
combined with filters to remove compounds with similar chemotypes to those in the training 
dataset. We would expect substantially reduced enrichment factors in such a scenario. 
Methods   
Experimental high-throughput screen for mGlu5 potentiators and hit validation 
In the initial HTS experiment, 144,475 compounds were tested for allosteric potentiation of 
mGlu5 using full automation in conjunction with the Vanderbilt HTS facility
3
. The Vanderbilt 
screening library is composed of commercially available compounds selected for maximum 
structural diversity from ChemBridge and ChemDiv vendors. Receptor-induced intracellular 
release of calcium in response to agonist treatment was measured in a fluorometric assay by 
utilizing an imaging-based plate reader (FDSS6000, Hamamatsu, Japan) that makes simultaneous 
measurements of calcium levels in each well of a 384 plate (Figure 6a).  
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Figure 6: FDSS measurement of intracellular Ca2+ release in response to mGlu5 activation 
and potentiation by allosteric modulator compounds: a) Agonist induced Ca
2+
 transients were 
quantified based on the fluorescence change observed in cells treated with an EC20 concentration 
of glutamate plus candidate allosteric potentiator compounds (dashed line trace) versus with 
glutamate alone (solid line trace). b) Putative primary screen hits showed potentiation of the 
glutamate response and were confirmed by testing for concentration-dependent activity on mGlu5 
over a range of 4 log units with 10 point concentration response curves (30 µM – 1 nM final 
concentration). Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; 
Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. 
W.; Conn, P. J.; Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 
Potentiators Using Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-
305. Copyright 2010 American Chemical Society. 
 
HEK 293A cells stably expressing mGlu5 were plated in black-walled, clear-bottomed, poly-D-
lysine coated 384-well plates (BD Biosciences, San Jose, CA) in 20 µL assay medium (DMEM 
containing 10% dialyzed FBS, 20 mM HEPES, and 1 mM sodium pyruvate) at a density of 20K 
cells/well. The cells were grown overnight at 37 °C in the presence of 6% CO2. The next day, 
medium was removed and the cells incubated with 20 µL of 2 µM Fluo-4, AM (Invitrogen, 
Carlsbad, CA) prepared as a 2.3 mM stock in DMSO and mixed in a 1:1 ratio with 10% (w/v) 
pluronic acid F-127 and diluted in assay buffer (Hank‟s balanced salt solution, 20 mM HEPES 
and 2.5 mM Probenecid (Sigma-Aldrich, St. Louis, MO)) for 45 m at 37 °C. Dye was removed, 
20 µL assay buffer was added and the plate was incubated for 10 m at room temperature. Ca
2+
 
flux was measured using the Functional Drug Screening System. As a result, 1,382 compounds 
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were confirmed as potentiators of the mGlu5 glutamate response and used to build QSAR 
models. Interestingly, several scaffolds with substantial differences in their chemical structures 
resulted from this experimental screen including benzoxazepine (Figure 6a), phenylethynyl, and 
benzamide derivatives (Figure 5a-c; manuscript in preparation). 
For further analysis the mGlu5 PAM library of active compounds in the original HTS screen as 
well as the compounds selected for post-screening were clustered using the Mathematica 
package
93
. The Tanimoto coefficient based on number atoms in the maximum common 
substructure served as distance metric: 
Equation 2: 
                       
                  
                                  
 
 
In an initial primary screen of ANN selected compounds, single concentrations of compounds (30 
µM final) were transferred to daughter plates using the Echo acoustic plate reformatter (Labcyte, 
Sunnyvale, CA). Compounds were diluted into assay buffer to a 2x stock using a Thermo Fisher 
Combi (Thermo Fisher, Waltham, MA) which was applied to cells at t = 3s. Cells were incubated 
with test compounds for 140 s, stimulated for 74 s with an EC20 concentration of glutamate and 
then stimulated for 32 s with an EC80 concentration of glutamate. Data were collected at 1 Hz. 
Agonist induced Ca
2+
 transients were quantified based on the fluorescence change observed in 
cells treated with an EC20 concentration of agonist (glutamate) +/- concentrations of candidate 
allosteric potentiator compounds. Putative hits from the primary screen were confirmed by testing 
for concentration-dependent activity on mGlu5 over a range of 4 log units (Figure 6b). 
Compounds were serially diluted 1:3 into 10 point concentration response curves (30µM – 1nM 
final), transferred to daughter plates using the Echo acoustic plate reformatter and tested as 
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described in the primary screen. Concentration response curves were generated using a four point 
logistical equation with XLfit curve fitting software for Excel (IDBS, Guildford, UK).  Within 
this software suite, equation number 200 under the category Dose Response One Site with 
formula   
 
   
 
 
  
 was utilized.  
Generation of numerical descriptors for training of QSAR models  
For input to machine learning methods the chemical structure of each molecule needs to be 
described numerically (see Figure 7a). Initially, 3D models of all 144,475 small molecules are 
generated using the CORINA software package
6
. From the 3D structural models a set of 1,252 
numerical descriptors is computed using the ADRIANA software
5
. The descriptors can be 
classified into 35 categories including eight scalar descriptors, eight 2D and eight 3D auto-
correlation functions, eight radial distribution functions, and three surface-auto-correlation 
functions (see Table 2). 
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Figure 7: Overall model generation workflow: a) active and inactive molecules were retrieved 
as MDL SD files from experimental collaborators; 3D  structures were generated with CORINA 
and used as input for calculation of molecular descriptors using ADRIANA; b) active molecules 
were oversampled 106 times to balance data sets; c) molecules were randomly included in 
training dataset (80%), monitoring dataset (10%), and independent dataset (10%); d) iterative 
training of ANN models coupled with e) input sensitivity analysis was used to reduce and 
optimize the descriptor set until no further improvement in the quality criteria for the independent 
dataset was achieved. Reprinted with permission from Mueller, R.; Rodriguez, A. L.; Dawson, E. 
S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; Bleckmann, A.; Weaver, C. D.; Lindsley, C. 
W.; Conn, P. J.; Meiler, J., Identification of Metabotropic Glutamate Receptor Subtype 5 
Potentiators Using Virtual High-Throughput Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-
305. Copyright 2010 American Chemical Society. 
Oversampling was used for balanced training 
As detailed above, 1,382 compounds were confirmed to be active potentiators of the mGlu5 
glutamate response (0.94% hit rate). Of these, only 1,356 compounds were used as „actives‟ in 
model generation due to difficulty of encoding charged molecules with ADRIANA (see Figure 
7a). We refer to the active dataset as these 1,356 compounds. All other compounds were 
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classified as inactive. In order to maximize information content of the final prediction method, the 
dataset needs to contain an equal number of active and inactive compounds when training – i.e. 
its entropy is maximized. Otherwise a method that would predict all compounds as inactive 
would be right 99% of the time but completely useless. Balancing was achieved through 
oversampling (Figure 7b). Active compounds were used in training the ANNs 106 times more 
frequently to account for their smaller number compared to the inactive set of compounds (0.94% 
hit rate, see Figure 7b,c,d).  
In principle balancing of the training data can be achieved by two approaches: oversampling of 
active compounds or undersampling of inactive compounds. Oversampling approaches avoid 
removal of part of the inactive compounds, hence utilize all available information for model 
development, and should therefore yield better results. However, undersampling has the 
advantage that models can be trained more quickly as only a fraction of the data needs to be 
fitted. To validate that oversampling gives optimal QSAR models for the present application, two 
models were developed with different strategies of undersampling inactive compounds and the 
optimized descriptor set (276 descriptors). The independent dataset was kept identical to the 
oversampling scenario to enable direct comparison. For training and monitoring datasets (i) a 
random selection of inactive compounds was selected and (ii) the inactive compounds most 
similar to active compounds were chosen using MACCS fingerprint keys
71
 and Tanimoto 
coefficient as similarity measure. 
A monitoring dataset was introduced to early terminate ANN training 
The natural logarithm of the experimentally determined      value of each compound   was used 
as output for the ANN models (             ). Compounds classified as inactive were 
assumed to have an         . The root mean square deviation        between 
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experimental activity      and predicted activity       (see Equation 1) is used as objective 
function when training the ANN models. 
For training ANNs the dataset is split. Of the total experimental dataset, 115,581 (80%) data 
points were used for the ANN training (Figure 7c,d). 14,448 (10%) data points were set aside for 
monitoring during ANN training and initiate early termination (Figure 7c,d). After each training 
iteration the      of the monitoring dataset was computed. Training was terminated once the 
     value of the monitoring dataset was minimized. The final 14,448 data points (10%) were 
reserved for independent testing of QSAR models (see Table 3). Care was taken to avoid any 
overlap between training, monitoring, and independent dataset. All results reported were obtained 
for the independent dataset unless noted differently.  
Artificial neural network (ANN) architecture and training  
ANNs are machine learning algorithms that reflect characteristics of biological neural systems in 
a much simplified fashion. The simplest ANN consists of several layers of neurons           
containing    neurons each. In a pair-wise fashion neurons in neighboring layers are interlinked 
by weighted connections     (Figure 2b). These connections represent the degrees of freedom of 
the ANN which are optimized during the training procedure. The input data    to every neuron 
are summed up according to their weights and modified by the activation function  :  
Equation 3: 
        (∑      
 
) 
The output        then serves as input to the  -th neuron of the next layer (Figure 2b).  
For the present setup the input vector 〈 〉 to the first layer consists of the chemical descriptors 
introduced above. The single output number of the last layer that contains only one neuron is the 
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experimentally determined biological activity     . The present ANNs have up to 1,252 inputs 
(Figure 2a), 8 hidden neurons (Figure 2b), and 1 output (Figure 2c). The sigmoid function  
Equation 4: 
     
 
     
 
is applied as activation function   of the neurons. The training method used is resilient back-
propagation of errors
10b
, a supervised learning approach. The difference between the experimental 
activity      and predicted activity       determines the change of each weight within the back-
propagation of errors. Ultimately the root mean square deviation (    , Equation 1) between 
experimental and predicted biological activity is minimized. The ANNs were trained with up to 
40,000 iterations of Resilient Propagation. However, training was terminated early when the 
monitoring dataset achieved its minimum     . The training took up to 13 hours per network 
using eight cores of a core2 quad 2.33GHz Intel Xeon microprocessor in parallel on the 64-bit 
version of Red Hat Enterprise Linux 5.2.  
Selection of the optimal set of descriptors of chemical structure 
Optimization of the descriptor set was achieved by systematic removal of molecular descriptor 
groups that were least significant for prediction of PAM activity (Figure 7e; Figure 2a). Objective 
of this procedure is to reduce the total number of inputs and therefore the total number of weights 
of the ANN (Figure 7d, e; Figure 2a). It is advantageous to remove obsolete descriptors in order 
to minimize the number of degrees of freedom (weights) that need to be determined. In the 
process, training and prediction of ANNs is accelerated. Further, noise is reduced while the ratio 
of data points versus degrees of freedom increases. 
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To determine the significance of each input, the ANN is first trained using the complete set of 
1,252 descriptors (Table 2). After completion of the training the ANN represents a 
multidimensional function: 
Equation 5: 
   (           )    〈 〉  
with input values             and output  . The partial derivative of each input with respect to 
the output can be determined numerically and is introduced as “input sensitivity”:  
Equation 6: 
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For this purpose each input value    is altered by a small     in an independent experiment and 
the change    is monitored. Following this procedure the input sensitivity is determined for each 
input   by selecting randomly 100 compounds from the independent dataset. The input    is 
perturbed by a small number     = ±5 % of the input range. The output change    is recorded
94
. 
The input sensitivity of input   is the average ratio observed (Equation 6). 
The input sensitivity of each of the 27 non-scalar descriptor categories was determined as norm 
over the individual input sensitivity values within this category. The descriptor categories were 
sorted by input sensitivity. All 3D autocorrelation, Radial Distribution Function and Surface 
Autocorrelation descriptors with an input sensitivity above 0.06 were used to train an 
oversampled model with 428 descriptors while descriptors with a smaller input sensitivity were 
removed. Approximately 2/3 (65%) of the total input sensitivity were maintained by 
implementing approximately 1/3 (34%) of the total number of descriptors. This reduction sped up 
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the training process by a factor of 3. The least significant descriptor category was removed in 
subsequent iterations of descriptor optimization (see Figure 2a). This procedure was repeated 
until further removal of descriptors did not result in an increase of prediction accuracy for the 
independent data set (see Figure 7c-e; Figure 2a). 
Enrichment and area under the curve       as quality measures 
As mentioned before, the rmsd between predicted experimental LnEC50 was used as objective 
function for training the ANNs. EC50 values for compounds classified as inactive were assumed 
to be 1mM. Analysis of the rmsd proved to be a poor indicator for model quality (see Table 3) as 
the correlation coefficients between experimental and predicted LnEC50 values are typically 
smaller than 0.5 (see Figure 8). 
 
Figure 8: Correlation plot between measured and predicted LnEC50 values. Inactive 
compounds were set to an EC50 of 1mM (LnEC50= -6.9). The solid lines represent the cutoff used 
for acquisition of compounds (EC50 of 1μM / LnEC50= -13.82). Reprinted with permission from 
Mueller, R.; Rodriguez, A. L.; Dawson, E. S.; Butkiewicz, M.; Nguyen, T. T.; Oleszkiewicz, S.; 
Bleckmann, A.; Weaver, C. D.; Lindsley, C. W.; Conn, P. J.; Meiler, J., Identification of 
Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput 
Screening. ACS Chem. Neurosci. 2010, 1 (4), 288-305. Copyright 2010 American Chemical 
Society. 
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Note that for the application of these models as tools in virtual screening (read below) binary 
classification is the important criteria as in the end a binary decision for compound acquisition is 
made. Hence, all models were also assessed in terms of binary classification based on enrichment 
and area under the curve (   ).  
Receiver operating characteristic (ROC) curves were generated as a measure to evaluate 
predictive power of the machine learning approaches. ROC curves plot the rate of true positives 
   or                ⁄  versus the rate of false positives    or                     
   ⁄     ⁄  of a binary classifier.    represents the number of true positives and    the 
number of false positives within this subset.   represents the total number of positives and   the 
total cases known to be negative. Here biological activity was used as binary classifier (Figure 3). 
The diagonal represents the performance expected from a random predictor. The larger the     of 
a ROC curve the larger is the predictive power of the model. 
For prediction of biological activity often only the very initial part of the ROC curve is of interest. 
This is the area containing the compounds with the highest predicted biological activity. As after 
a virtual screen of a compound library, only a small percentage (typically 0.1-1.0%) of 
compounds predicted to be maximally active will enter biological tests (only this fraction of the 
ROC curve will be actually used in the virtual screen). The     value is a poor measure of 
predictive power in this region of the ROC curve as it measures overall performance.  
Therefore, often the initial slope of the ROC curve is analyzed using so-called “          ” 
values. Enrichment measures the factor by which active compounds (positives) are increased 
relative to inactive compounds (negatives) when selecting a subset of data predicted with the 
highest confidence levels by a model: 
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Equation 7: 
           
  
     
 
   
⁄  
When computed for the independent dataset the            represents the expected factor by 
which the fraction of active compounds is increased in an in silico virtual screen when compared 
to the chance of finding active compounds in an unbiased dataset (here 0.94%). Note that 
enrichment values are always coupled to a certain cutoff, the fraction of molecules retained after 
filtering. The enrichments reported in Table 3 were determined for a cutoff of 0.35%. As an 
example, this would correspond to filtering 1,000 compounds out of a library of about 300,000. 
As the models were trained with continuous LnEC50 values but largely applied in a binary 
classification setting we tested if training of the models as pure binary classifiers offered any 
advantages. A model was trained where all active compounds were given an activity of „1‟ and all 
inactive compounds were set to „0‟. For the independent dataset, an auc of 0.744 and an 
enrichment of 26 were calculated. However, this procedure did not yield an improvement over 
models trained with continuous LnEC50 values (see Table 3). This approach was not pursued 
further. 
Implementation 
The ANN algorithm was implemented in the BioChemistryLibrary (BCL). The training method 
used is Resilient Propagation, a supervised learning approach
10
. Further detail is given above. The 
BCL is an in house developed object-oriented library written in the C++ programming language. 
It consists currently of approximately 400 classes and 300,000 lines of code. ADRIANA
5
 was 
used for generation of chemical descriptors. CORINA
6
 was used for generation of three-
dimensional structures.  
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CHAPTER III 
VIRTUAL HIGH-THROUGHPUT SCREENING AS A ROBUST TOOL TO IDENTIFY 
METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 4 POTENTIATORS 
Introduction 
This study implements a machine learning approach (Artificial Neural Networks) to virtually 
screen commercially available compounds for potentiators of metabotropic glutamate receptor 
subtype 4 (mGlu4). Marino and Conn
13b, 95
 showed that activation of mGlu4 is a viable option in 
treating Parkinson‟s disease. Parkinson‟s disease (PD) is a debilitating movement disorder that 
afflicts more than 1 million people in North America. In Parkinson‟s patients, there is a decrease 
in GABAergic transmission at the inhibitory striatopallidal synapse within the basal ganglia; this 
abnormality is thought to contribute to the motor dysfunctions observed in PD patients. Current 
PD treatments that are focused on dopamine-replacement strategies ultimately fail in most 
patients because of loss of efficacy and severe adverse effects that worsen as the disease 
progresses
13a, 96
. Selective activation of mGlu4 could provide palliative benefit in PD. Further, 
selectively targeting mGlu4 avoids the loss of efficacy and severe side-effects of long-term 
dopamine replacement therapy. In 2003 Maj
28
 et al. reported on the discovery of (-)-PHCCC, the 
first positive allosteric modulator of mGlu4 with demonstrated selectivity for group III mGlus, 
but also a partial antagonist for mGlu1 (group I). Around the same time, Mathiesen
29
 et al. 
showed that SIB-1893 and MPEP (a known mGlu5 antagonist
31
) are mGlu4 potentiators.   
Despite their tractability as drug targets, the majority of GPCR-based drug discovery programs 
have failed in the past to yield highly selective compounds. The traditional approach to target the 
endogenous ligand orthosteric binding site has suffered from a paucity of suitably subtype-
selective ligands as orthosteric binding sites are highly conserved between GPCR subtypes. An 
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alternative approach is to target allosteric sites that are topographically distinct from the 
orthosteric site, either enhancing or inhibiting receptor activation
97
. Discovery and 
characterization of allosteric modulators of GPCRs has gained significant momentum over the 
last few years, especially since the clinical validity of GPCR allosteric modulators was 
demonstrated with two allosteric modulators entering the market
98
. Thus, allosteric modulation 
represents an exciting novel means of targeting GPCRs particularly for CNS disorders, a 
therapeutic area with one of the highest rates of attrition in drug discovery
99
.  
Recently, Niswender
4b
 et al. reported the discovery of 434 potentiators of mGlu4 from a high-
throughput screen of approximately 155,000 compounds. The study highlighted a series of 
cyclohexyl amides joined to a substituted phenyl ring. The structures of these tested molecules 
and their experimentally determined EC50 towards mGlu4 potentiation were employed in the 
model described in this paper. Engers et al.
4a
 discuss the synthesis and evaluation of a set of 
heterobiarylamides that were derived from the aforementioned compounds and optimized for 
penetrating the central nervous system. Around the same time, several pyrazolo[3,4-
d]pyrimidines were also described to be novel mGlu4 positive allosteric modulators
4c
. Two 
challenges in further developing potentiators of mGlu4 as a PD treatment strategy are the low hit-
rate of 0.3% in the original high-throughput screen resulting in a small number of available 
ligands and the “flat” structure activity relationship (SAR) around the „proof of concept‟ 
compound PHCCC. Even slight structural modifications lead to complete loss of activity for the 
reported compounds
4d
. The present study addressed both challenges by identifying additional 
allosteric potentiators from commercially available compound libraries and exploring the 
chemical space around the known active compounds. 
Quantitative structure activity relationship (QSAR) models describe the often complex, non-
linear relation between the chemical and physical properties of molecules and their biological 
activity; for a review of different methods see Todeschini et al. or Hansch
65
. Classical QSAR was 
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introduced by Hansch et al. by deriving biological activity from electron density
66
. Modern 
QSAR techniques employ advanced 2D molecular fingerprints and 3D molecular descriptors 
coupled with machine learning
7, 67
. In this study, artificial neural networks (ANNs) were trained 
on descriptors computed with the software package ADRIANA
5
 linking chemical properties of 
small molecules to their potency as potentiators of mGlu4. 
Fragment-independent scalar descriptors, 2D and 3D surface and auto-correlation functions, and 
radial distribution functions are employed to encode a large diversity of chemotypes into 
comparable mathematical representations
1
. 
ANNs have been successfully applied in biochemistry to generate QSAR models
7, 85-88
. Our group 
recently published a theoretical comparison of machine learning techniques for identification of 
compounds that are predicted allosteric modulators of the mGlu5 glutamate response
1, 89
. 
Results and Discussion 
Artificial Neural Networks (ANNs) were trained to predict the capability of drug-like molecules 
for allosteric potentiation of the metabotropic glutamate receptor subtype 4 (mGlu4) based on a 
high-throughput screen as reported by Niswender et al
4b
. Commercially available databases of 
small molecules were virtually screened for novel potentiators of mGlu4. Hit compounds were 
verified experimentally. 
Descriptor categories were selected according to input sensitivity 
Several of the descriptor categories (see Table 4) employ the same chemical property but 
different encoding functions (2D vs. 3D auto-correlation and Radial Distribution Functions). 
Therefore, a descriptor optimization strategy was employed to identify the smallest set of 
descriptors needed for optimal QSAR models. Using this technique, the number of parameters 
(weights) in the ANNs is reduced, improving the signal-to-noise ratio for the trained models. To 
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determine the „least necessary‟ descriptor categories, the input sensitivity (see Methods) of each 
input with respect to the output of the ANN, i.e. biological activity prediction, was determined. 
Table 4: Summary of 1,252 molecular descriptors in 35 categories computed with ADRIANA 
 Description Method Description Property Abbreviation Number 
1 Scalar descriptors Molecular weight of compound  Weight 1 
2  Number of hydrogen bonding acceptors HDon 1 
3  Number of hydrogen bonding donors HAcc 1 
4  Octanol/water partition coefficient in [log units] XlogP 1 
5  Topological polar surface area in [Å2] TPSA 1 
6  Mean molecular polarizability in [Å3] Polariz 1 
7  Dipole moment in [Debye] Dipol 1 
8  Solubility of the molecule in water in [log units]  LogS 1 
9 2D Autocorrelation atom identities 2DA_Ident  11 
10  σ atom charges 2DA_SigChg 11 
11  π atom charges 2DA_PiChg 11 
12  total charges 2DA_TotChg 11 
13  σ atom electronegativities 2DA_SigEN 11 
14  π atom electronegativities 2DA_PiEN 11 
15  lone pair electronegativities 2DA_LpEN 11 
16  effective atom polarizabilities 2DA_Polariz 11 
17 3D Autocorrelation atom identities 3DA_Ident  12 
18  σ atom charges 3DA_SigChg 12 
19  π atom charges 3DA_PiChg 12 
20  total charges 3DA_TotChg 12 
21  σ atom electronegativities 3DA_SigEN 12 
22  π atom electronegativities 3DA_PiEN 12 
23  lone pair electronegativities 3DA_LpEN 12 
24  effective atom polarizabilities 3DA_Polariz 12 
25 Radial Distribution Function atom identities RDF_Ident  128 
26  σ atom charges RDF_SigChg 128 
27  π atom charges RDF_PiChg 128 
28  total charges RDF_TotChg 128 
29  σ atom electronegativities RDF_SigEN 128 
30  π atom electronegativities RDF_PiEN 128 
31  lone pair electronegativities RDF_LpEN 128 
32  effective atom polarizabilities RDF_Polariz 128 
33 Surface Autocorrelation molecular electrostatic potential Surf_ESP 12 
34  hydrogen bonding potential  Surf_HBP 12 
35  hydrophobicity potential Surf_HPP 12 
 Total 1252 
 
Optimization of molecular descriptor set improves prediction results 
An ANN was trained using only the scalar descriptors 1-8 to report a baseline performance using 
only naïve descriptors (Figure 9 and Table 5). The     value of 0.631 serves as a basis for 
comparison in model optimization (Table 5). The            equals 1.2 at a compound cutoff 
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of 2%. The relative root mean square deviation (    ) value for the independent data set is 
0.238. „Total Polarizable Surface Area‟ was the input with the highest sensitivity (0.87) in this 
model with the other descriptor sensitivities ranging from 0.07 („Dipole Moment‟) to 0.48 
(„Hydrogen Bond Acceptors‟). The second baseline model involved all 1,252 descriptors as 
inputs. The     and            values improved to 0.708 and 7.3, respectively, while the 
     dropped to 0.234. 
 
Figure 9: Receiver Operating Characteristic (ROC) curve plot for classical, all, and jury 
approach (round 1): This plot compares traditional QSAR (eight scalar descriptors, dotted grey 
line) with utilizing all (1,252, dotted black) available ADRIANA descriptors and a jury approach 
(solid black line). It demonstrates that ADRIANA descriptors add to the classical approach and 
that a jury approach improves performance even further. The inset shows the first 20% of the 
False Positive rate. 
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In a first round of descriptor optimization, one third of the descriptor categories with the lowest 
input sensitivity (Equation 11) were removed. Note that the scalar descriptors were kept in all 
models to facilitate comparison with the baseline. This procedure leads to a final model 
containing 741 descriptors in 21 categories (see Table 5) with a slightly worse statistical profile: 
   : 0.703,      : 0.227,           : 7.1. The second round yielded a model with 578 
descriptors in 17 categories. The quality measures were better than the model with all descriptors 
with an     of 0.706,      of 0.229, and an improved            of 13.0. The last iteration 
left 415 descriptors in 13 categories. While the     value (0.804) and      value (0.222) 
improved, the             (10.7) dropped. 
Table 5: The     ,    , and            values for all round 1 mGlu4 QSAR models 
Iteration 
Number and type of 
descriptors 
                      
  train monitor independent  at 2% 
All 1252 1-35 0.204 0.232 0.234 0.708 7.3 
Scalar 8 1-8 0.232 0.236 0.239 0.631 1.2 
1 741 
1–8, 14–16, 21–23, 
25, 29–33, 35 
0.224 0.224 0.227 0.703 7.1 
2 578 
1–8, 15–16, 23, 25, 
30 – 33, 35 
0.187 0.212 0.229 0.706 13.0 
3 415 
1–8, 15, 25, 30–31, 
35 
0.192 0.211 0.222 0.804 10.7 
Jury - - 0.159 0.214 0.207 0.732 15.4 
       
 
Jury model combines favorable features of all previous models 
As these QSAR models have a comparable quality and enrichment values are affiliated with high 
uncertainties, a jury approach was tested to combine models. An ANN was trained on the output 
of the three ANNs with the reduced descriptor sets (see Figure 10). This procedure improved the 
critical            value to 15.4 and reduced the      to 0.207 (see Table 5). The     value is 
with 0.732, a value lower than the 0.804 value reported for the ANN model with 415 descriptors. 
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However, the improved performance of this model results from the second half of the ROC curve, 
which is not employed  when predicting molecules with high activities (Figure 11). 
 
Figure 10: Schematic view of the jury system: The output of the best three ANNs according to 
the quality measures reported in Table 5 were employed as inputs for a jury ANN with four 
hidden neurons. 
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Figure 11: Receiver Operating Characteristic (ROC) curve plot for 415, 578, 741, and jury 
approach (round 1): The three optimized descriptor sets (415: long dotted black line, 578: dotted 
gray line, 741: dotted black line) perform similarly well as the jury approach (black line). 
However, the jury approach is more stable compared to the three other ANNs, as can be seen in 
Table 5. 
Radial Distribution Functions (RDFs) carry most of the input sensitivity 
As more descriptors are removed from the inputs, the input sensitivity values increase for RDFs 
(see Figure 12). Specifically, RDFs for π- and lone pair electronegativity always play an 
important role. RDFs for identity and polarizability are featured most prominently in the model 
with 578 descriptors which is the best non-jury network (see Table 5). The importance of these 
descriptors immediately makes sense, since the active compounds of the original high-throughput 
screen often feature phenyl rings and amide substructures that are well described by such RDFs. 
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Figure 12: Schematic view of an ANN: The input to the ANN consists of up to 1,252 descriptors 
in 35 categories. The weighted sum of the inputs is propagated through the activation function 
and fed into the hidden layer (8 neurons). The output is the predicted value of the logarithm of the 
EC50 of the small molecule towards potentiation of glutamate response at the metabotropic 
glutamate receptor 4. The heat map shows the input sensitivity of each category from lowest (red) 
to highest (green). 
Virtual screening of ChemBridge compound library  
The ANN QSAR model was applied in a virtual screen of the ChemBridge database of 
commercially available compounds. In silico screening of the entire library of ~450,000 
compounds took approximately ten hours on a regular personal computer. A total of 1,108 
compounds with predicted      values below 3μM for mGlu4 PAM activity were selected. 
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The compounds identified in the virtual screen were ordered from ChemBridge and tested at the 
Vanderbilt HTS facility. These compounds were screened in single point at a 10 µM (nominal) 
concentration using the human mGlu4/Gqi5 calcium mobilization assay as well as the rat mGlu4 
thallium flux assay described in Niswender et al. Compounds that scored as 3 standard deviations 
higher than the control      response population (168 compounds) were then moved to screening 
in concentration-response curve format in both assays. 67 compounds were confirmed as 
potentiatiors in both assays, representing an                   ⁄            ⁄     
relative to the initial experimental HTS hit rate. The experimental enrichment is consistent with 
the enrichment values predicted from analysis of an independent dataset during development of 
the QSAR model, given the large uncertainty of these values (Table 5). 
Hits and misses of virtual screening overlap with known actives 
The 67 newly identified mGlu4 PAM compounds contained eight benzo-oxazoles, 42 furan-
amides including 22 thioureas, and three phenylbenzamides. All three compound classes were 
represented in the original HTS hits and featured only trivial R-group modifications (53 total 
compounds, Figure 13).  Experimentally inactive compounds from these classes included 72 
phenylbenzamides, 193 benzo-oxazoles, and 213 furanamides . A second round of training was 
attempted incorporating the results from the first round to increase the chemical diversity in the 
model. 
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Figure 13: Scaffold category analysis (round 1): (I) Scaffold composition of 432 mGlu4 PAMs 
from HTS. mGlu4 PAMs were clustered with the Mathematica package using the Tanimoto 
coefficient of the largest common substructure as distance measure. Three major scaffolds are 
constituted by 37 phenylbenzamides (8.5%, a), 96 benzo-oxazoles (22.2%, b), and 39 (9.0%, c) 
furan-amides. (II) Scaffold composition of 67 active compounds in the postscreen. (III) Scaffold 
composition of inactive compounds in the postscreen. Compounds d, e, and f are examples for 
active compounds identified by the virtual HTS, where g, h, and i were found to be inactive. 
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Second round of predictions focused on scaffold-hopping 
The known actives from the initial HTS combined with the 67 newly identified mGlu4 PAMs and 
a set of additional bromofurans comprised the set of 504 active compounds used to generate the 
second round model. The data set also contained 149,778 inactive compounds. Models were 
trained employing the same sets of descriptors and jury setup (see Figure 14 and Table 6).  
 
Figure 14: Receiver Operating Characteristic (ROC) curve plot for 415, 578, 741 
descriptors, and jury approach (round 2): The models for 415 (gray), 578 (dashed black), 741 
descriptors (black), and jury (dotted black) achieve almost identical performance. The inset shows 
the first 20% of the False Positive rate. 
Table 6: The     ,    , and            values for all round 2 mGlu4 QSAR models 
Iteration 
Number and type of 
descriptors 
                      
  train monitor independent  at 2% 
1 741 
1–8, 14–16, 21–23, 
25, 29–33, 35 
0.191    0.225 0.224 0.657 12.1 
2 578 
1–8, 15–16, 23, 25, 
30 – 33, 35 
0.189 0.224 0.232 0.649 15.1 
3 415 
1–8, 15, 25, 30–31, 
35 
0.186 0.231 0.236 0.647 11.1 
Jury - -  0.172  0.228 0.236 0.655 14.1 
60 
 
 
However, to improve the diversity of compound predictions, a higher cutoff of      = 20 μM 
was chosen and all compounds identified by any of the models 1-3 were considered. Out of a total 
of 36,930 compounds predicted to be active, compounds with TPSA < 130Å
2
 and XlogP <4.0 
were retained (leaving 17,268 molecules). Compounds containing reactive fragments were then 
removed leaving 12,218 compounds. Finally, compounds that had a large overlap with a known 
active compound (>0.65 similarity based on molecular graph) were removed leaving 2,015 
compounds. Additional compounds predicted at a potency cutoff of 3 μM were then combined 
with this set (2,777 compounds total) and vetted for removal of any remaining promiscuous and 
reactive groups leading to a final order of 2,630 compounds for experimental testing. 
These compounds were tested using the hmGlu4 Gqi5 assay, again in single point with 166 
compounds moving to CRC testing. These studies identified 70 previously unknown mGlu4 
active compounds giving an                   ⁄            ⁄    relative to the initial 
experimental HTS hit rate. The enrichment was expected to be substantially lower than in the first 
round due to the higher      cutoff of 20 μM compared to 3 μM (Table 6). 
Non-trivial modifications of known actives constitute 59% of newly identified PAMs 
Out of the 70 newly identified active compounds, 61 constituted mGlu4 PAMs. The set of the 61 
PAMs contained four benzisoxazoles, and 21 furanyl amides, classes which were represented in 
the original HTS hits (Figure 15). The remaining 36 PAMs consisted of ten biaryl anilines, two 
aryl ketones, seven aryl ethers, three aryl thioethers, ten phenyl sulfonylamides, and four novel 
singletons with diverse scaffolds. Hence, 59% (36/61) of the newly identified PAMs showed non-
trivial modifications of hits of the original HTS. One of the biaryl anilines (Figure 15d) is similar 
to compounds patented by ADDEX 
100
. The biaryl compound shown in Figure 15e has not been 
reported in the literature thus far as an mGlu4 PAM. 
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Figure 15: Scaffold category analysis (round 2): (I) Scaffold composition of 504 mGlu4 PAMs 
from HTS and first round vHTS. mGlu4 PAMs were clustered with the Mathematica package 
using the Tanimoto coefficient of the largest common substructure as distance measure. The three 
major scaffolds from round 1 are represented by 39 phenylbenzamides (7.7%, a), 23 benzo-
oxazoles (4.6%, b), and 88 (17.5%, c) furan-amides. (II) Scaffold composition of 70 active 
compounds in the postscreen. (III) Scaffold composition of inactive compounds in the postscreen. 
Compounds d, e, and f are examples for active compounds identified by the virtual HTS, where g, 
h, and i were found to be inactive. 
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Conclusions 
Artificial Neural Networks were trained to generate QSAR models from an HTS experimental 
dataset of compounds with mGlu4 positive allosteric modulator activity. A jury system, based on 
the three ANN models, generated improved enrichments when compared to each individual 
model. The enrichment factor of 22 determined from biological testing of 1,108 compounds 
prioritized from a commercial library of ~450,000 substances demonstrates the predictive power 
of the method. This enrichment factor agrees well with the theoretically expected enrichment of 
36. A second round of virtual screening using models that had been refined with the results from 
the first screen identified 36 compounds with novel chemotypes that have mGlu4 potentiation 
activity. This approach therefore allows screening of external libraries for target-specific lead-like 
candidate molecules around known scaffolds but also has the potential to identify novel 
chemotypes. 
Methods 
Balancing the data by oversampling 
Only 0.3% (432 molecules) of the whole data set (156,146 molecules) was active. For training the 
dataset was oversampled by a factor of 360 (see Figure 16)
1
. This lead to an oversampled data set 
with 311,234 molecules where approximately half of the data points were active and the other 
half inactive. 
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Figure 16: Overall model generation workflow: a) Colleen Niswender provided SD files with 
active and inactive compounds towards mGlu4 determined by HTS and CRC; CORINA and 
ADRIANA were employed to generate 3D structures and molecular descriptors; b) active 
molecules were oversampled 360 times to balance data sets; c) molecules were randomly 
distributed between training (80%), monitoring (10%), and independent (10%) datasets; d) ANNs 
were trained and e) low sensitivity  descriptors were removed until the quality measures (see 
Table 5) no longer improved; the best three ANNs were combined into a jury network. 
Translating molecular structures into input numerical descriptors 
To determine the input for the ANNs, 3D models of all 156,146 molecules from the original HTS 
were generated using CORINA
6
. These models served as input for the ADRIANA
5
 software 
package. All 35 categories (scalar, 2D/3D auto-correlation, RDF (eight each), surface auto-
correlation (three), see Table 4) were computed implementing the default values in each category. 
Approximately 4% of all molecules were not properly encoded by ADRIANA and removed from 
the data set. The final data set consisted of 298,914 data points. 
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From biological data to output         
The experimentally determined      values of the active compounds ranged from 94.4nM to 
17.8μM. To distinguish between active and inactive compounds, all inactive compounds were set 
to an arbitrary potency of 1mM. The output for training the ANN consisted of the natural 
logarithm of the          values ranging from -16.2 (most active) over -10.9 (least active) to -6.9 
(inactive). The root mean square deviation (    ) between experimental and predicted      
values was employed as objective function in training the ANNs: 
Equation 8: 
     √
∑              
 
   
 
 
 
Monitoring data set determines progress and termination of training 
From the 298,914 data points in the oversampled data set, 239,132 (80%) were employed in the 
actual training of the ANN. The monitoring data set consisted of 29,891 data points (10%). The 
rmsd between experimental and predicted          was computed for the monitoring data set 
after each iteration over the full training data set. Once the rmsd stabilized, the training was 
terminated, and the rmsd of the remaining 10% (independent data set) computed (see Table 5). 
Care was taken to avoid overlap between training, monitor, and independent data set. 
A three-layered ANN was trained implementing Resilient Propagation 
The trained ANNs consisted of the input layer with up to 1,252 chemical descriptors, the hidden 
layer consisting of eight neurons, and one neuron in the output layer predicting the          of 
the described molecule. The sigmoid function  
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Equation 9: 
     
 
     
 
served as activation function of the neurons. The ANNs were trained by implementing resilient 
back-propagation of errors
10b
, a supervised learning approach. The training was terminated after 
up to 40,000 iterations when the monitoring dataset achieved its minimum rmsd. It took up to 13 
hours per network using eight cores of a core2 quad 2.33GHz Intel Xeon microprocessor in 
parallel on the 64-bit version of Red Hat Enterprise Linux 5.2. 
Jury system combines output of three best networks 
The outputs of the three best ANNs were used as input for a jury ANN that consisted of three 
inputs, four hidden neurons, and one output. The training of the jury ANN terminated after 290 
steps. 
Selection of the optimal set of descriptors of chemical structure 
It is crucial to select the optimal set of descriptors from the 35 available categories. In a top-down 
approach, the least significant categories for predicting          were successively removed to 
increase the predictive power of the according ANNs. The advantage lies in removing degrees of 
freedom from the ANN by reducing the number of inputs. Since the number of data points stays 
the same, the signal-to-noise ratio improves. This procedure is described in detail elsewhere
1
. 
The ANN can be thought of as a multidimensional function: 
Equation 10: 
   (           )    〈 〉  
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with input values             and output  . The partial derivative of each input with respect to 
the output can be determined numerically and is introduced as “input sensitivity”:  
Equation 11: 
                  (
   
   
)
    
 
 
   
∑
  
   
   
   
 
 
For this purpose each input value    is altered by a small     = ±0.05 *    in an independent 
experiment and the change    is monitored94. Following this procedure the input sensitivity is 
determined for each input   by selecting 100 random compounds from the independent dataset. 
The input sensitivity of input   is the average ratio observed (Equation 11). 
The input sensitivity of each of the 27 non-scalar descriptor categories was determined as norm 
over the individual input sensitivity values within this category. The descriptor categories were 
sorted by input sensitivity. In each step, categories comprising the least 10% of input sensitivity 
were removed. This process was repeated until the quality measures did no longer improve (see 
Table 5 and Table 6). 
Enrichment and area under the curve complement rmsd as quality measures 
Analysis of the rmsd proved to be a poor indicator for model quality (see Table 5 and Table 6). 
Hence, all models were also assessed in terms of their binary classification power using 
enrichment and area under the curve (   ) quality measures. Receiver operating characteristic 
(ROC) curves were generated as a measure to evaluate predictive power of the machine learning 
approaches. ROC curves plot the rate of true positives    or                ⁄  versus the rate 
of false positives    or                        ⁄     ⁄  of a binary classifier.    
represents the number of true positives and    the number of false positives within this subset.   
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represents the total number of positives and   the total cases known to be negative. Here 
biological activity was used as binary classifier (see Figure 9, Figure 11, and Figure 14). The 
diagonal represents the performance expected from a random predictor. The larger the     of a 
ROC curve the larger is the predictive power of the model. 
For prediction of biological activity, often only the very initial part of the ROC curve is of 
interest. This is the area containing the compounds with the highest predicted biological activity. 
After a virtual screen of a compound library, only a small percentage (typically 0.1-1.0%) of 
compounds predicted to be maximally active will enter biological tests (only this fraction of the 
ROC curve will be actually used in the virtual screen). Therefore, often the initial slope of the 
ROC curve is analyzed using so-called “          ” values. Enrichment measures the factor by 
which active compounds (positives) are increased relative to inactive compounds (negatives) 
when selecting a subset of data predicted with the highest confidence levels by a model: 
Equation 12: 
           
  
     
 
   
⁄  
 
When computed for the independent dataset the            represents the expected factor by 
which the fraction of active compounds is increased in an in silico virtual screen when compared 
to the chance of finding active compounds in an unbiased dataset (here 0.28%). Note that 
enrichment values are always coupled to a certain cutoff, the fraction of molecules retained after 
filtering. The enrichments reported in Table 5 and Table 6 were determined for a cutoff of 2%. As 
an example, this would correspond to filtering 9,000 compounds out of a library of about 
450,000. 
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Implementation 
The ANN algorithm was implemented in the BioChemistryLibrary (BCL). The training method 
used is Resilient Propagation, a supervised learning approach
10
. Further detail is given above. The 
BCL is an in house developed, object-oriented library written in the C++ programming language. 
It currently consists of approximately 400 classes and 300,000 lines of code. ADRIANA
5
 was 
used for generation of chemical descriptors. CORINA
6
 was used for generation of three-
dimensional structures. 
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CHAPTER IV 
IDENTIFICATION OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 
NEGATIVE ALLOSTERIC MODULATORS USING VIRTUAL HIGH-THROUGHPUT 
SCREENING 
Introduction 
Artificial Neural Networks (ANNs) were trained to predict the capability of drug-like molecules 
for allosteric inhibition of the metabotropic glutamate receptor subtype 5 (mGlu5) based on a 
high-throughput screen of 345 confirmed negative allosteric modulators (NAMs) and 155,774 
compounds showing no activity towards mGlu5. Commercially available databases of small 
molecules were virtually screened for novel inhibitors of mGlu5. Hit compounds were verified 
experimentally. For an overview and introduction to allosteric modulation of mGlu5 see 
Gasparini et al
12b
. 
Biology and pharmacology of metabotropic glutamate receptors 
Pin et al
47b
 gave a review of the metabotropic glutamate receptors in 1995. They discuss the 
different subtypes (mGlu1 to mGlu8) and their organization into three groups based on cloning 
results, furthermore transduction mechanisms for the cloned receptors, and pharmacology 
including certain ligands. In the chapter on structure and function they describe the seven 
transmembrane helices, the glutamate binding site, and the G-protein coupling. Multiple 
alignments of the mGlus and the closely related PCaR1 show conserved residues. Residues 
affecting glutamate affinity are marked. The last two chapters discuss transduction mechanisms 
of native mGlus and their physiological roles. 
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This work was updated and expanded by Conn and Pin
11
 in 1997. Potential clinical uses are 
mentioned as well as the role of mGlus as presynaptic autoreceptors and in regulating ion 
channels.  
After updating this information in Pin et al (1999)
15
, the authors move on to discuss the 
development of selective ligands for each group of mGlus. Pharmacophore models for the 
glutamate binding site are reported. The remainder of the paper highlights additional regulatory 
sites on the mGlus which could be utilized for allosteric modulation.  
Negative allosteric modulation of mGlu5 could allow treatment of fragile X syndrome 
Dölen and Bear
14
 give a review of studies connecting negative allosteric modulation to the 
treatment of fragile X syndrome which can cause mental retardation and autism. Fragile X 
syndrome is triggered by mutational deactivation of the fragile X mental retardation protein 
(FMRP) which inhibits protein synthesis. It is therefore thought of as the natural opponent of 
mGlu5 regulating translation of mRNA at the synapse. Negative allosteric modulation of mGlu5 
could reestablish this balance between mGlu5 potentiation and FMRP inhibition of protein 
synthesis, therefore ameliorating symptoms of fragile X syndrome.  
For a general overview of the therapeutic potential of allosteric modulation of G-protein coupled 
receptors see Conn, Christopoulos, and Lindsley
16
. 
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 
The first potent and selective negative allosteric modulator 2-Methyl-6-(phenylethynyl)-pyridine 
(MPEP) was reported by Gasparini et al
31
 in 1999. Several papers were published analyzing the 
binding pocket of MPEP
25, 101
, its augmentation of PCP-induced cognitive deficits
55a, b
, and the 
development of MPEP into a radioligand
33
. 
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Rodriguez et al
35
 show that an MPEP-like ligand could block the effect of multiple allosteric 
modulators and therefore function as a neutral allosteric ligand. In 2009 the same group reported 
the discovery and structure-activity relationship of mGlu5 antagonists different from the MPEP 
scaffold
36
. 
High-Throughput Screening in Drug Discovery  
High-throughput screening is the process where a large (several thousand to millions) library of 
small molecule ligands is screened in an automated fashion for a beneficial property in an assay. 
The 120 GPCR-based HTS assays published in PubChem (pubchem.ncbi.nlm.nih.gov, accessed 
April 2011) address targets like RGS16-Gαo (AID1441, primary screen, 826 active out of 218,535 
tested) and 5-hydroxytryptamine (serotonin) receptor subtype 1a (5HT1a) (AID567, primary 
screen, 366/64,907). However, the hit rate in these examples is always around 0.5%, meaning 
99.5% of the screened compounds are inactive towards the target. Increasing the hit rate to 5% 
through virtual high-throughput screening would enrich the screen by a factor of 10, meaning 
only 10% of the molecules need to be tested to get the same number of active compounds and 
henceforth reducing screening cost and time. 
Rodriguez et al
3
 screened approximately 160,000 small molecules to identify modulators of 
mGlu5. The primary triple-add calcium flux assay revealed 624 potential antagonists. In the 
confirmatory screen employing full concentration response curves, 345 antagonists were verified. 
This HTS data is the basis for the virtual HTS experiment described in this chapter. Additional 
experiments determining functional diversity and in vivo activity of the novel allosteric 
modulators were reported.  
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Virtual High-Throughput Screening  
Virtual HTS allows searching for modulators of a given biological target by means of a 
quantitative structure activity relationship. A model is trained on the structure of small molecules 
with known activity towards the target. Under the assumption that structurally similar targets 
have similar activity, a database of virtual or commercially available small molecules is screened 
for compounds with similar structural features resulting in similar activity.  
Noeske et al
19
 utilized virtual HTS to search for mGlu1 NAMs. The top five compounds of 
similarity searches on the Asinex Gold Collection (194,563 compounds in 2003) with six known 
inhibitors of mGlu1were ordered together with eight compounds that were identified in at least 
three of the six runs regardless of rank. Among the 23 compounds that were delivered one had 
sub-µM activity, five were between 1µM and 15µM, and the remaining 17 compounds were 
above 15µM. The same group expanded this approach
20
 by training a self-organizing map (SOM) 
on the COBRA database of pharmacologically relevant compounds. Therefore they described the 
structure of each molecule by CATS-2D topological atom-pair descriptors which describe the 
molecule by binning bond distances between chemically relevant groups of atoms. Known 
inhibitors of mGlu1 were clustered near two neurons in the SOM. Molecules in the Asinex Gold 
Collection were projected onto the SOM. Compounds in the vicinity of these two neurons were 
manually inspected and 28 screening candidates ordered. One molecule showed activity below 
1µM, five between 1 and 15µM in an rmGlu1 assay. 
Describing Chemical Structure for QSAR  
Recently, the focus for describing chemical structure for QSARs has been more on fragment-
independent descriptors because of the higher flexibility in describing small molecules. Other 
examples besides the aforementioned CATS-2D topological descriptors are radial basis and 
surface auto-correlation functions
5
. 
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Establishing QSAR in Drug Discovery 
The importance and examples of QSAR in drug discovery are discussed in detail in the 
introductions of chapters II and III. For an overview on QSAR methods see Hansch et al
65a
. 
Machine learning and QSAR 
Winkler et al
7
 reviews how neural networks can be employed in establishing QSARs. 
Furthermore, it provides a general introduction to neural networks and their training. 
Machine learning models were trained on locally available high-throughput screening data to 
predict biological activity of small molecule ligands towards negative allosteric modulation of 
metabotropic glutamate receptor subtype 5. A set of 749 compounds was ordered and tested in a 
triple-add calcium flux assay. Negative allosteric modulators were enriched by a factor of seven 
and a new scaffold of NAMs was identified. 
Results and Discussion 
Optimization of molecular descriptor set improves prediction results 
The ANN trained on all 35 descriptor categories available in the ADRIANA descriptor set (see 
Table 7) achieved an root mean square deviation (rmsd) of the independent data set of 0.209, 
area under the curve (auc) of 0.83, and enrichment of 18.8. For the first optimization the four 
least sensitive descriptor categories were removed leading to an rmsd of 0.199, auc of 0.87, and 
enrichment of 28.2. Removing eight more descriptor categories led to the optimal model with 763 
descriptors and to an rmsd of 0.201, auc of 0.86, and enrichment of 37.6. Further reduction of the 
number of descriptors led to slightly worse models which were not considered for further 
predictions (see Figure 17). 
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Enrichment is the critical quality measure for virtual screening 
While rmsd and auc identified the general quality of the trained ANNs, these quality measures 
captured the overall quality of the models including prediction of inactive compounds. However, 
the success of a model is based on identification of active compounds for ordering. So the 
emphasis of the quality measures was placed on the enrichment that predicts the ratio of correctly 
identified NAMs in the final order. 
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Table 7: Summary of 1,252 molecular descriptors in 35 categories computed with ADRIANA 
 Description Method Description Property Abbreviation Number 
1 Scalar descriptors Molecular weight of compound  Weight 1 
2  Number of hydrogen bonding acceptors HDon 1 
3  Number of hydrogen bonding donors HAcc 1 
4  
Octanol/water partition coefficient in [log 
units] 
XlogP 1 
5  Topological polar surface area in [Å
2
] TPSA 1 
6  Mean molecular polarizability in [Å
3
] Polariz 1 
7  Dipole moment in [Debye] Dipol 1 
8  
Solubility of the molecule in water in [log 
units]  
LogS 1 
9 2D Autocorrelation atom identities 2DA_Ident  11 
10  σ atom charges 2DA_SigChg 11 
11  π atom charges 2DA_PiChg 11 
12  total charges 2DA_TotChg 11 
13  σ atom electronegativities 2DA_SigEN 11 
14  π atom electronegativities 2DA_PiEN 11 
15  lone pair electronegativities 2DA_LpEN 11 
16  effective atom polarizabilities 2DA_Polariz 11 
17 3D Autocorrelation atom identities 3DA_Ident  12 
18  σ atom charges 3DA_SigChg 12 
19  π atom charges 3DA_PiChg 12 
20  total charges 3DA_TotChg 12 
21  σ atom electronegativities 3DA_SigEN 12 
22  π atom electronegativities 3DA_PiEN 12 
23  lone pair electronegativities 3DA_LpEN 12 
24  effective atom polarizabilities 3DA_Polariz 12 
25 
Radial Distribution 
Function 
atom identities RDF_Ident  128 
26  σ atom charges RDF_SigChg 128 
27  π atom charges RDF_PiChg 128 
28  total charges RDF_TotChg 128 
29  σ atom electronegativities RDF_SigEN 128 
30  π atom electronegativities RDF_PiEN 128 
31  lone pair electronegativities RDF_LpEN 128 
32  effective atom polarizabilities RDF_Polariz 128 
33 Surface Autocorrelation molecular electrostatic potential Surf_ESP 12 
34  hydrogen bonding potential  Surf_HBP 12 
35  hydrophobicity potential Surf_HPP 12 
 Total 1252 
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Figure 17: Receiver Operating Characteristic (ROC) curve plot for 416, 555, 683, 763, 972, 
and all descriptors: While the models with 972 and 763 descriptors perform well over the whole 
ROC curve, the other models clearly show reduced performance in the middle part of the ROC 
curve. However, in the beginning of the curve all of the models look very similar. Based on the 
enrichment (see Table 8) the model with 763 descriptors was chosen for predicting active 
compounds to be ordered. 
Table 8: The     ,    , and            values for all mGlu5 NAMs QSAR models
Iteration 
Number and type of 
descriptors 
                      
  train monitor independent  (at 0.3%) 
All 1252 1-35 0.184 0.203 0.209 0.83 18.8 
1 972 
1–19, 21–26, 29–32, 
34– 35  
0.168 0.202 0.199 0.87 28.2 
2 763 
1–9, 11, 12, 14, 15, 
17, 21–23, 25, 29 – 
32, 35 
0.157 0.201 0.201 0.86 37.6 
3 683 
1–8, 14, 23, 25, 29 – 
32, 35 
0.178 0.204 0.210 0.84 9.4 
4 555 
1–8, 14, 23, 25, 29 – 
31, 35 
0.189 0.204 0.218 0.81 28.2 
5 416 
1–8, 23, 25, 30, 31, 
35 
0.180 0.210 0.215 0.82 9.4 
77 
 
Predictions focused on scaffold-hopping 
The ANN with the highest enrichment for mGlu5 NAMs (Table 8, iteration 2) was employed to 
virtually screen the ChemDiv (San Diego, CA) Discovery Chemistry database of 708,416 (May 
2008) commercially available drug-like compounds. Only compounds which had a Tanimoto 
coefficient based on size of substructure of less than 0.6 compared to locally known mGlu5 
NAMs were considered for ordering. This emphasized identifying new scaffolds with low 
similarity to known inhibitors. 
Results of virtual screening of ChemDiv compound library 
The model predicted a set of 42,041 small molecules at a 10µM potency cutoff from the virtual 
screen. Molecules with a weight above 600Da, 130Å
2
 total polarizable surface area, cLogP of 4.0, 
or labile or reactive fragments were sorted out. Removal of molecules with a substructure 
similarity above 0.6 led to the final order of 749 compounds. These compounds were 
subsequently tested at the Vanderbilt Institute for Chemical Biology high-throughput screening 
center to reveal a single point concentration hit rate of 12% (88/749 compounds) that included 51 
antagonists (NAMs), 18 positive allosteric modulators (PAMs) and 19 agonists. Concentration 
response curves at 10 concentrations (1nM to 30µM range) confirmed 12 NAMs, 14 PAMs and 1 
partial agonist compound (3.6% hitrate) representing an enrichment factor of 15.7 for mGlu5 
activity compared with the original mGlu5 experimental screening data (0.22% hit rate). 
Compounds with confirmed antagonist (NAM) activity (1.6%) were enriched by a factor of 7.0 
with novel mGlu5 NAM scaffolds. 
Virtual High-Throughput Screening identified new scaffold of mGlu5 NAMs 
Two mGlu5 NAMs with an IC50 of 75 and 124nM, respectively, were identified resembling a 
formerly unknown scaffold of mGlu5 inhibitors. 
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Figure 18: Two novel mGlu5 NAMs sharing a previously unknown scaffold.Two of the 51 
NAMs identified in an order of 749 compounds. These compounds were confirmed in 
concentration response curves revealing activities of 75 (left) and 124nM (right). 
Conclusions 
The latest virtual HTS experiment reported here had the lowest ratio of active compounds in the 
original screen (0.22%). Nevertheless, it was possible to train stable machine learning QSARs on 
this sparse data. The enrichment of 7.0 for mGlu5 NAMs was lower compared to the enrichment 
for mGlu5 PAMs. This was expected because of the emphasis on scaffold hopping in generating 
the compound set to order. These efforts proved finally successful by identifying two mGlu5 
NAMs with activities around 100nM sharing a novel scaffold compared to known mGlu5 NAMs. 
Methods 
Translating molecular structures into input numerical descriptors 
To determine the input for the ANNs, low energy conformations of all 156,146 molecules from 
the original HTS were generated using CORINA. These models served as input for the 
ADRIANA software package. All 35 categories (scalar, 2D/3D auto-correlation, RDF (eight 
each), surface auto-correlation (three), see Table 7) were computed implementing the default 
values in each category. Eighteen (5.2%) of the 345 known inhibitors were not properly encoded 
by ADRIANA and removed from the data set leading to a set of 327 properly encoded inhibitors. 
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ADRIANA failed to encode a similar rate of 7,291out of 155,774 (4.7%) inactive compounds 
leaving 148,483 correctly encoded inactive compounds. 
Balancing the data by oversampling 
To keep the ANN from predicting all compounds as being inactive, the training data needs to be 
balanced. Each of the 327 properly encoded inhibitors was represented 451 times in the training 
data set (147,477 entries compared to 148,483 inactive compounds for a total of 296,936 entries). 
From biological data to output 
The experimentally determined      values of the active compounds ranged from 4.8nM to 
20μM. To distinguish between active and inactive compounds, all inactive compounds were set to 
an arbitrary potency of 1 mM. The output for training the ANN consisted of the natural logarithm 
of the          values ranging from -19.2 (most active) over -10.8 (least active) to -6.9 
(inactive). The root mean square deviation (    ) between experimental and predicted      
values was employed as objective function in training the ANNs: 
Equation 13: 
     √
∑              
 
   
 
 
Monitoring data set determines progress and termination of training 
From the 296,936 data points in the oversampled data set, 237,550 (80%) were employed in the 
actual training of the ANN. The monitoring data set consisted of 29,693 data points (10%). The 
rmsd between experimental and predicted          was computed for the monitoring data set 
after each iteration over the full training data set. Once the rmsd stabilized, the training was 
terminated, and the rmsd of the remaining 10% (independent data set) computed (see Table 8). 
Care was taken to avoid overlap between training, monitor, and independent data set. 
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A three-layered ANN was trained implementing Resilient Propagation 
The trained ANNs consisted of the input layer with up to 1,252 chemical descriptors, the hidden 
layer consisting of eight neurons, and one neuron in the output layer predicting the          of 
the described molecule. The sigmoid function  
Equation 14: 
     
 
     
 
 
served as activation function of the neurons. The ANNs were trained by implementing resilient 
back-propagation of errors
10
, a supervised learning approach. The training took up to 40,000 
iterations of Resilient Propagation. However, training was terminated early when the monitoring 
dataset achieved its minimum rmsd. The training took up to 13 hours per network using eight 
cores of a core2 quad 2.33GHz Intel Xeon microprocessor in parallel on the 64-bit version of Red 
Hat Enterprise Linux 5.2. 
Selection of the optimal set of descriptors of chemical structure 
It is crucial to select the optimal set of descriptors from the 35 available categories. In a top-down 
approach, the least significant categories for predicting          were successively removed to 
increase the predictive power of the according ANNs. The advantage lies in removing degrees of 
freedom from the ANN by reducing the number of inputs. Since the number of data points stays 
the same, the signal-to-noise ratio improves. This procedure is described in detail elsewhere
1
. 
The ANN can be thought of as a multidimensional function: 
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Equation 15: 
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with input values             and output  . The partial derivative of each input with respect to 
the output can be determined numerically and is introduced as input sensitivity:  
Equation 16: 
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For this purpose each input value    is altered by a small     = ±0.05 *    in an independent 
experiment and the change    is monitored94. Following this procedure the input sensitivity is 
determined for each input   by selecting 100 random compounds from the independent dataset. 
The input sensitivity of input   is the average ratio observed (Equation 16). 
The input sensitivity of each of the 27 non-scalar descriptor categories was determined as norm 
over the individual input sensitivity values within this category. The descriptor categories were 
sorted by input sensitivity. In each step, categories comprising the least 10% of input sensitivity 
were removed. This process was repeated until the quality measures did no longer improve (see 
Table 8). 
Enrichment and area under the curve as binary quality measures 
The            measures the quotient of the rate of active compounds (true positives over all 
predicted active) in the predicted hits of the virtual HTS over the rate of actives (positives over all 
compounds) in the original HTS. It depends on the cutoff of compounds in the virtual HTS which 
here was set to 0.3% of all compounds. This is lower than the actual cutoff utilized for driving the 
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scaffold hopping. Therefore, the actual enrichment of seven was lower than the theoretical 
enrichments reported in Table 8. 
Equation 17: 
           
  
     
 
   
⁄  
The                          measures the overall quality of the model. It is a real number 
between (usually) 0.5 and 1 with 0.5 representing random prediction of activity and 1 describing 
perfect prediction. 
Both measures are based on the correct binary prediction of a compound being active or not in 
contrast to a non-discrete measure like     . 
Implementation 
The ANN algorithm was implemented in the BioChemistryLibrary (BCL). The training method 
used is Resilient Propagation, a supervised learning approach
10
. Further detail is given above. The 
BCL is an in house developed, object-oriented library written in the C++ programming language. 
It currently consists of approximately 400 classes and 300,000 lines of code. ADRIANA was 
used for generation of chemical descriptors
5
. CORINA was used for generation of three-
dimensional structures
6
. 
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CHAPTER V 
PREDICTING CARBON CHEMICAL SHIFTS EMPLOYING MACHINE-LEARNING 
METHODS 
Introduction 
13
C NMR spectroscopy is a powerful tool in structure elucidation of natural products and product 
validation in organic chemistry. In particular, the comparison of experimentally determined NMR 
chemical shifts with predicted chemical shifts can provide critical information to determine the 
constitution of an unknown compound
102
. Similarly, in synthetic organic chemistry, comparison 
of the 
13
C NMR spectrum of the synthesized compound with a predicted spectrum can reveal the 
success of the synthesis. 
Widely used approaches for predicting chemical shifts include ab initio calculations, empirical 
methods (e.g., lookup of similar compounds in databases, incremental correction systems), 
machine learning approaches such as artificial neural networks, and combinations thereof. 
Ab initio methods are computationally expensive and lack accuracy 
Ab initio calculations determine the chemical shifts by computing magnetic properties directly 
from a given conformation of the substance. Recently, Mulholland et al. utilized the Logic for 
Structure Determination (LSD) program to suggest a composition for the natural product angelon 
103
. The LSD program allows the scientist to input constraints derived from NMR data and from 
this data, suggests an ensemble of structures that fulfill these constraints. The correctness of the 
solution was demonstrated by comparing the experimental 
13
C chemical shifts with values 
calculated from the predicted structure by means of GAUSSIAN
104
, a quantum chemistry 
software program. The rmsd between the nine experimental and calculated 
13
C chemical shifts is 
2.71ppm. Another example is given by Bagno
105
, who summarizes computational work using 
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GAUSSIAN 03 and the Amsterdam Density Functional (ADF) suite to determine chemical shifts 
for a number of different chemical elements. Perez et al.
106
 compare the experimental values of 
two chloropyrimidines with four carbon atoms each to the ACD database approach (see below, 
rmsd 3.75ppm) and different ab initio methods, e.g. HF(bs1)s1//HF(bs1) (rmsd 4.53ppm). For a 
general overview of ab initio methods to predict 
13
C chemical shifts see Cimino et al.
107
. The 
authors report the corrected mean absolute error (cmae) for about 50 different chemical shift 
calculation setups ranging from 1.49 to 3.35ppm. 
Database methods rely on large sets of stored spectra. 
In contrast to ab initio methods, empirical approaches derive chemical shifts not from first 
principles but rely on large data sets of known compounds with assigned chemical shifts. 
Database approaches employ similarity searches, while incremental methods and machine 
learning approaches derive rules to compute the chemical shifts from similar substances. 
The capacities of modern computer systems make it feasible to collect large numbers of chemical 
structures together with assigned 
13
C NMR chemical shifts. Examples include the BIORAD 
KnowItAll database which is based on the CSEARCH database (~4,000,000 
13
C chemical shifts), 
MODGRAPH NMRPredict (~3,500,000 
13
C chemical shifts), SpecInfo database (~1,500,000 
13
C 
chemical shifts), ACD/CNMR (~2,160,000 
13
C chemical shifts), NMRShiftDB (~200,000 
13
C 
chemical shifts, www.nmrshiftdb.org), and the Spectral Database for Organic Compounds 
(SDBS, ~ 130,000 
13
C chemical shifts). 
The prediction of the 
13
C chemical shifts of a compound based on such a database usually 
happens one atom at a time. For each carbon atom the database is searched for structures that 
contain carbon atoms in similar chemical settings with known chemical shifts. The most difficult 
challenge is to encode the chemical environment of an atom in a way that can be easily searched. 
Examples are the Hierarchically Ordered Spherical description of Environment code (HOSE) or 
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the Simplified Molecular Input Line Entry System (SMILES) code. Satoh et al.
44
 describe the 
CAnonical representation of STereochemistry code (CAST) which explicitly accounts for the 
stereochemistry of the atom . 
However, database approaches have certain drawbacks: The storage space required increases 
linearly with the number of molecules represented. The access-time increases logarithmic with 
the size of the database. Further, use of these methods is problematic for novel compound classes 
of e.g. natural products that are not well represented in the database. In Perdue et al.
108
 the 
commercial ACD software gives an rmsd of 1.52ppm for a set of 29 differently substituted 
aromatic natural compounds. In Meiler
109
 a HOSE code prediction on the SpecInfo database 
reaches an rmsd of 2.60ppm for 100 compounds that were previously not in the database. 
Incremental methods are fast but lack accuracy  
Incremental methods determine the influence of substituents or structural elements like rings or 
double bonds on the chemical shift of an atom. Usually the increments are determined from 
databases of chemical shifts using multiple linear regressions (MLR). Assuming that all these 
influences are uncoupled, all terms are summed to estimate the chemical shift of a given carbon 
atom. This simple mathematical model allows for rapid computation. Current implementations of 
this method work well for many classes of organic substances. However, the deviations between 
predicted shift and experimental value increase for highly substituted and sterically restrained 
compounds. The interaction between two or more of these structural elements makes it necessary 
to introduce cross-correlation terms into the model. Due to the large number of potential cross-
correlation terms, such an approach becomes quickly intractable.  
Cheeseman et al.
104
 compared GAUSSIAN and ChemNMR Pro predictions for Taxol, an anti-
cancer drug. The mean absolute errors in this case are 3.80ppm for ChemNMR and 4.20ppm for 
GAUSSIAN. Perdue et al.
108
 developed an incremental approach (SPARIA) for distinguishing 
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substitution patterns in natural aromatic compounds. In this case, eight different substituents in 
five different positions around an aromatic ring lead to 16,640 unique substitution patterns. The 
rmsd of 2.27ppm is slightly worse than the rmsd of 1.52ppm for the ACD database approach on 
the same compounds discussed above. 
Artificial neural networks combine speed and accuracy 
Machine learning approaches such as artificial neural networks (ANNs) can combine the 
advantages of database and incremental approaches due to their inherent capability to model 
correlations between different substituents. This allows the ANN to reach a higher accuracy than 
incremental methods without requiring storage of a large database of chemical shifts as the 
chemical shift databases are only used in the training step of the ANN. The ANN can be re-
trained as new databases become available. For an overview on applications of ANNs in 
chemistry and more specifically in NMR see
110
. The accuracy level of ANNs can reach that of 
database approaches
109
 (rmsd 2.7ppm ANN vs. 2.6ppm SpecInfo for a set of 100 newly formed 
compounds). ANNs were used to predict chemical shifts for several classes of compounds, like 
acrylonitrile copolymers
111
 (rmsd 1.47ppm) or trisaccharides
112
 (rmsd 1.30-1.85ppm). Other 
implementations cover the complete space of small organic molecules, like 
109
 (rmsd 2.1ppm) and 
113
 (rmsd 4ppm). Blinov
114
 trained an ANN on the aforementioned ACD/Labs database and tested 
it by predicting 
13
C shifts for the NMRShiftDB (rmsd 1.59ppm). 
Atom environment code by sphere 
An important precondition to train and test ANNs is the encoding of the chemical environment of 
each carbon atom as a vector of numerical input values. Meiler previously introduced a 
modification of the aforementioned HOSE code to translate chemical information into input for 
an ANN
46
. 
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This chapter describes the introduction of a novel encoding scheme for the constitution of a small 
molecule and training of an ANN to predict carbon chemical shifts. This new encoding scheme 
widens the prediction capabilities of the ANN by including a larger variety of atom types, in 
particular charged atoms and solvent dependencies. Furthermore, through the use of exclusively 
publicly available databases for training the ANN, it is possible to provide a free-access tool 
(bcl::shift) to the scientific community. To address the smaller size of publicly available carbon 
chemical shift databases (~10% of commercial databases), the substituents around the atom of 
interest were summed up in spheres based on the bond distance to the atom of interest reducing 
the number of inputs for the ANN. This ANN was expanded in a second experiment to include 
stereochemical descriptors based on calculated partial charges. 
The flexible encoding scheme implemented in the BCL allows for the easy incorporation of new 
atom types to describe molecules with novel features. The ANN allows the prediction of 
13
C 
chemical shifts for molecules containing C, H, N, O, S, F, Cl, Br, I, P, B, Se, and Si. 
Iterative Partial equalization of orbital electronegativity determines σ-charges 
Gasteiger and Marsili
115
 described a method for determining the distribution of σ-charge in a 
small molecule. It is based on iterative partial equalization of orbital electronegativity (PEOE). 
First, all atoms in the molecule get assigned a base electronegativity according to their element 
type and hybridization and a σ-charge of zero. Based on their electronegativity, connected atoms 
will exchange partial charge. This in turn changes the electronegativity which is described by a 
quadratic polynomial fitted through orbital electronegativity data by Hinze and Jaffe
116
. 
Electronegativity and σ-charges stabilize after six iterations to give the final σ-charges. 
Gasteiger and Marsili
117
 used PEOE in 1981 to predict proton chemical shifts from the charge at 
the corresponding hydrogen atom. They showed a linear correlation between charge and shift of 
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the hydrogen. However, no linear correlation could be found between the proton chemical shift 
and the charge at the heavy atom (mostly carbon) the hydrogen is connected to. 
Hueckel molecular orbital method determines π-charges of conjugated systems 
The π-charges of conjugated systems can be determined by the Hueckel molecular orbital (HMO) 
method (see for instance
118
). It minimizes the energy of the conjugated system taking only the 
energy of an electron in the field of the atom core (Coulomb integral) and interactions between 
neighboring atoms (exchange integral). 
Marsili and Gasteiger
119
 provide a parameterization to describe π-electronegativity as a quadratic 
function of the π-charge in a similar fashion as described earlier for σ-charges and σ-
electronegativity. They also suggest including σ-charges into the Coulomb integral of the HMO 
to distinguish different substituents which are not parts of the conjugated system themselves. 
Results and Discussion 
A combination of resilient and simple back-propagation is used to achieve optimal training 
results. 
The training of the ANN with 317 inputs started with a fast decrease in the rmsd of the 
monitoring dataset using resilient back-propagation (Figure 19). However, after 20,000 training 
periods the rmsd showed oscillating behavior. This was due to a well-known effect of the resilient 
propagation training algorithm (discontinuity around zero)
120
. Switching to the slower simple 
back-propagation training algorithm stabilized the training behavior and allowed the rmsd to be 
minimized. The monitoring data set showed very similar results to the training data indicating 
that overtraining had been avoided. As expected, the independent test data showed slightly 
weaker results. 
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Figure 19: The training of the ANN with 317 descriptors started with approximately 20,000 
steps using the resilient propagation algorithm (fast training, steep decline). The rest of the 
training (~660,000 steps) was accomplished with simple propagation. The first jump in the curve 
denotes the point after ca. 44,000 steps when the full data set was used for training (before: 50% 
of the data). The second dent denotes the point where a subset of the data was removed to 
improve training. 
Chemical shifts with a deviation above 17ppm are excluded from final training. 
To address the fact that some molecules have wrongly assigned shifts, all small molecules 
containing an atom with a difference between measured and predicted 
13
C chemical shift 
exceeding 17ppm were removed utilizing the model with 317 descriptors trained 20,000 periods 
of resilient propagation on the full dataset. This left 13,229 molecules out of 14,598 (90.6%). 
The trained ANN predicts 
13
C chemical shifts with a mean average error of 2.95ppm.  
The best training results were achieved for an ANN with 317 inputs, 48 hidden neurons and 1 
output neuron. The input data consisted of 142,243 carbon atoms with 
13
C chemical shift values 
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in 13,229 molecules. The dataset was split into three smaller datasets:  113,795 shifts (80%) for 
training of the ANN, 14,224 (10%) for monitoring, and 14,224 (10%) for independent testing. 
The mean absolute error mae and the root mean square deviation rmsd in each of the three data 
sets was computed between all experimental chemical shifts and the shifts predicted by the ANN. 
The results are 2.44/3.42ppm for the training data, 2.51/3.54ppm for the monitoring data, and 
2.95/3.95ppm for the independent data. 
The ANN performs well for predicting 
13
C NMR spectra of organic compounds. 
To illustrate the reliability of the prediction method for a whole spectrum, the highest (Figure 20) 
and average (Figure 21) difference between measured and predicted chemical shifts in a molecule 
was computed. For 89.3% (11,815) of the molecules the mae was below 4ppm which is slightly 
worse than UpSol NMRPrediction (95% below 3.8ppm). Another 9.1% (1,209) had an mae 
between 4 and 6ppm, leaving 1.6% (205) molecules with a mae above 6ppm. Only 14 molecules 
had a mae above 10ppm. The ANN shows differences in prediction accuracy for the different 
carbon atom types (Table 9). The prediction accuracy decreases when going from sp3-hybridized 
carbon atoms over sp2-hybridized carbon atoms to sp-hybridized carbon atoms due to the more 
complex chemical environment and larger influence of π-conjugated systems. 
Table 9: The mae and rmsd of the shift prediction by the different carbon atom types 
element type #bonds Charge geometry #shifts mae/ppm rmsd/ppm 
Carbon 4 0 tetrahedral 58536 2.25 3.12 
Carbon 3 0 trigonal 81850 2.67 3.73 
Carbon 2 0 linear 1804 2.53 3.59 
Carbon 1 -1 - 22 1.38 2.07 
Carbon 3 -1 trigonal 4 1.50 1.56 
Total     2.50 3.49 
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Figure 20: Highest chemical shift prediction deviation per molecule. The histogram shows the 
distribution of the highest deviation between a single experimental and predicted 
13
C shift in each 
of all 13,229 molecules. 
 
Figure 21: Average chemical shift prediction deviation per molecule. The histogram shows 
the distribution of the mae between experimental and predicted 
13
C shifts per molecule for all 
13,229 molecules. 
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Predicting natural products with a mae of 3.29ppm. 
A small test set of 12 molecules with known 
13
C chemical shifts was used to determine the 
performance of the approach for natural products (Figure 22). The overall mae for the 263 shifts 
was 3.29ppm and the rmsd was 4.50ppm (see Table 10). 
Table 10: The rmsd between reported and predicted 
13
C chemical shifts for some natural 
products. 
structure Reference mae/ppm rmsd/ppm 
strychnine Singh 3.61 4.52 
 Verpoorte 
1976 
3.23 4.06 
 Srinivasan 4.00 5.36 
 Leung 3.30 4.21 
 Verpoorte 
1977 
3.23 4.08 
 Wenkert 3.09 3.88 
brucine Singh 3.39 4.30 
 Wehrli 2.85 3.67 
 Verpoorte 3.00 3.79 
 Srinivasan 3.74 5.15 
 Wenkert 3.09 3.72 
anthraquinone1 Xia 3.22 4.34 
anthraquinone2 Xia 2.84 4.61 
anthraquinone3 Xia 3.06 4.58 
subergorgia1 Qi 2.27 2.82 
subergorgia2 Qi 4.31 5.48 
subergorgia3 Qi 2.96 3.63 
5α-androstane Kalinowski 4.56 6.17 
5β-androstane Kalinowski 4.57 6.27 
cholesterol Kalinowski 3.14 4.41 
testosterone Kalinowski 2.73 3.50 
Verpoorte
121
 gives a table of different data sets for strychnine and brucine. Xia
122
 reports shifts for 
a new set of anthraquinones found in Halorosselinia, Qi
123
 for three new polyhydroxylated sterols 
from Subergorgia suberosa. The shifts for the steroids were taken from Kalinowski 
124
. The 
overall mae and rmsd for all 12 compounds (using the best mae/rmsd for strychnine/brucine) are 
3.29ppm and 4.50ppm, respectively. 
 
The C_SHIFT program introduced in 
109
 gave an overall rmsd of 3.42ppm. We attribute the 
difference in performance to the significantly smaller dataset available for training the method. 
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C_SHIFT was trained with ~1.5 million 
13
C chemical shifts of the Specinfo database compared to 
the ~185,000 
13
C chemical shifts used for bcl::shift. Looking only at taxol, the mae and rmsd are 
2.7ppm and 4.1ppm, respectively (maximal deviation 14.9ppm). This compares well to other 
methods discussed in 
109
 which achieved maes between 1.0ppm and 4.0ppm, rmsds between 
1.5ppm and 5.8ppm, and maximal deviations between 4.1ppm and 23.6ppm. 
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Figure 22: The set of 12 natural products. Brucine and strychnine were taken from 
Verpoorte
121
. Three anthraquinones found in Halorosselinia were reported by Xia
122
, Qi
123
 is the 
source for three polyhydroxylated sterols from Subergorgia suberosa. The steroids were taken 
from Kalinowski 
124
. The experimental 
13
C shifts are given in bold letters, the predicted in italic. 
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Descriptors were sorted by input sensitivity. 
After the conclusion of these experiments stereochemical descriptors were introduced into the 
model as described in Methods (see Table 13). An input sensitivity analysis determined the 
importance of each descriptor category. Therefore, ANNs with 16 hidden neurons were trained on 
10% of the total data set (18,306 chemical shifts). The input sensitivities are shown in  
Table 11. An input sensitivity of 0 means that the descriptor was not employed in this model. 
Table 11: Models with three different descriptor sets were trained: 1,525 (all), 1,038 
(2DAutoCorr_*Chg, 3DAutoCorr_Ident, _*Chg, RDF_*Chg, _PiEN, _Polariz), 701 
(RDF_*Chg). The descriptors on the left-hand side of the table were always employed.  
#descriptors 1,525 1,038 701 #descriptors 1,525 1,038 701 
atom_of_interest 0.051 0.078 0.123 2DAutoCorr Ident 0.047 0.000 0.000 
sphere1 
 
0.052 0.052 0.071 2DAutoCorr SigChg 0.129 0.079 0.000 
sphere2 
 
0.027 0.027 0.045 2DAutoCorr PiChg 0.159 0.093 0.000 
sphere3 
 
0.025 0.024 0.039 2DAutoCorr TotChg 0.134 0.129 0.000 
sphere4 
 
0.023 0.021 0.034 2DAutoCorr SigEN 0.042 0.000 0.000 
conjugated_sphere1 0.045 0.023 0.035 2DAutoCorr PiEN 0.023 0.000 0.000 
conjugated_sphere2 0.026 0.024 0.039 2DAutoCorr LpEN 0.009 0.000 0.000 
conjugated_sphere3 0.024 0.022 0.036 2DAutoCorr Polariz 0.021 0.000 0.000 
conjugated_sphere4 0.023 0.022 0.033 3DAutoCorr Ident 0.087 0.070 0.000 
bond_types1 0.027 0.042 0.053 3DAutoCorr SigChg 0.125 0.083 0.000 
bond_types2 0.034 0.030 0.043 3DAutoCorr PiChg 0.148 0.128 0.000 
bond_types3 0.009 0.014 0.030 3DAutoCorr TotChg 0.144 0.113 0.000 
bond_types4 0.006 0.007 0.010 3DAutoCorr SigEN 0.039 0.000 0.000 
bond_types5 0.006 0.007 0.008 3DAutoCorr PiEN 0.023 0.000 0.000 
ring_closure 0.016 0.015 0.024 3DAutoCorr LpEN 0.008 0.000 0.000 
solvent_properties 0.047 0.027 0.032 3DAutoCorr Polariz 0.022 0.000 0.000 
temperature 0.005 0.003 0.005 RDF Ident 0.049 0.000 0.000 
     
RDF SigChg 0.430 0.277 0.353 
     
RDF PiChg 1.519 1.725 2.880 
     
RDF TotChg 0.502 0.399 0.580 
     
RDF SigEN 0.039 0.000 0.000 
     
RDF PiEN 0.079 0.053 0.000 
     
RDF LpEN 0.041 0.000 0.000 
     
RDF Polariz 0.056 0.049 0.000 
Sum             1.705 1.819 2.965 
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RDF SigChg, PiChg, TotChg are the best conformational descriptors. 
Since the rmsd of the models trained on 10% of the data was inconclusive, each of the descriptor 
sets was employed to train a model on the full dataset. The model with 701 descriptors (317 
constitutional descriptors + 3*128 RDF SigChg, PiChg, TotChg) had the smallest overall rmsd 
after 20,000 periods of training utilizing resilient back-propagation of errors. 
A combination of resilient and simple back-propagation is used to achieve optimal training 
results. 
The model with 701 descriptors was trained to completion on the pruned dataset. The training of 
the ANN started with a fast decrease in the rmsd of the monitoring dataset using resilient back-
propagation (Figure 23). After 20,000 training periods all chemical shifts with a deviation greater 
17ppm between experimental and predicted values were removed. Another 20,000 steps of 
resilient propagation yielded no improvement. Switching to the slower simple back-propagation 
training algorithm allowed the final minimization of the rmsd. The monitoring data set showed 
very similar results to the training data indicating that overtraining had been avoided. As 
expected, the independent test data showed slightly weaker results. 
The trained ANN predicts 
13
C chemical shifts with a mean average error of 2.84ppm.  
The best training results were achieved for an ANN with 701 inputs, 48 hidden neurons and 1 
output neuron. The input data consisted of 181,786 carbon atoms with 
13
C chemical shift values 
in 17,336 molecules. The dataset was split into three smaller datasets:  146,112 shifts (80%) for 
training of the ANN, 18,402 (10%) for monitoring and 18,152 (10%) for independent testing. 
The mean absolute error mae and the root mean square deviation rmsd in each of the three data 
sets was computed between all experimental chemical shifts and the shifts predicted by the ANN. 
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The results are 2.55/3.42ppm for the training data, 2.79/3.65ppm for the monitoring data, and 
2.84/3.73ppm for the independent data. 
 
Figure 23: The training of the ANN with 701 descriptors. The training started with 
approximately 20,000 steps using the resilient propagation algorithm (fast training, steep decline). 
After 20,000 steps, all chemical shifts with a deviation greater 17ppm between experimental and 
predicted values were removed. Another 20,000 steps of resilient propagation yielded no 
improvement; the training was finished with simple back-propagation of errors. 
Including radial distribution function descriptors allows differentiation between configurations. 
To illustrate the capability of the trained ANN to differentiate between different configurations, 
two isomers (cis-/trans-2-buten-1-ol) were predicted with the final model. The code is still 
identical for the two sp2-carbons, since all distances to other atoms are the same for both isomers. 
However, the two sp3-carbons are described differently due to the changes in distance to (some 
of) the other atoms in the molecule. 
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Figure 24: The difference between the σ-charge radial distribution functions for carbon 1 in 
cis- (light gray) and trans-2-buten-1-ol (dark gray). The configurational changes occur between 
2.5 and 5Å. 
 
 
Figure 25: The difference between the σ-charge radial distribution functions for carbon 4 
(methyl) in cis- (light gray) and trans-2-buten-1-ol (dark gray). The peaks between 3 and 6Å are 
shifted due to the change in distance. 
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Figure 26: Comparison between experimental (bold) and predicted (italic) 
13
C chemical 
shifts for two isomers. While carbon 4 is predicted along the experimental values, the order of 
the shifts for carbon 1 is inversed. The experimental values were taken from SDBS
4c
. 
rmsd=3.6ppm(cis), 2.2ppm(trans), mae=2.7ppm(cis), 1.8ppm(trans) 
Growing 
13
C databases will improve prediction accuracy. 
Given the small size and the diversity of the trained dataset, the results compare well to similar 
works that incorporated larger and more homogenous databases like SpecInfo. Currently 
approximately 185,000 
13
C shifts were used for training the ANN. This is only about 10% of the 
1,500,000 shifts in the SpecInfo database used in previous approaches. As publicly available 
databases grow, the ANN will be retrained to improve prediction accuracy. 
Conclusions 
The publicly available data of the NMRShiftDB can be used to train an ANN to predict 
13
C 
chemical shifts with a mae of 2.95ppm (rmsd of 3.95ppm). For a subset of 12 natural products a 
mae of 3.29ppm (rmsd of 4.50ppm) was determined demonstrating the ability of the methods to 
predict the 
13
C chemical shifts of newly discovered natural products. The successful introduction 
of configurational and conformational descriptors was shown by an improved mae on the 
independent data set of 2.84ppm and comparing the predictions for cis-/trans-but-2-en-1-ol. The 
most current version of the bcl::shift prediction tool is available at www.meilerlab.org for 
academic use. 
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Methods 
Programming and data processing.  
All of the procedures described below are executed utilizing the object-oriented C++ 
BioChemistry Library (BCL) developed in the Meiler laboratory. The SD files provided by the 
NMRShiftDB were read, converted into BCL molecule and spectra objects, and stored in a 
MySQL database. The ANN is trained by back-propagation of errors (see below).  
Artificial neural network architecture. 
The ANN used is a feed-forward network trained with back-propagation of error. The ANN 
consists of 317 inputs for the numerical description of the chemical environment (see below). 
Those inputs are fully connected to a hidden layer with 48 neurons. To compute the output of 
each of these 48 hidden neurons the input data xi to the first layer are summed up according to 
their neuron-specific weights and modified by the sigmoid activation function:  
       [     (∑     
 
)]
  
 
 
The output fj then serves as input to single neuron of the final layer predicting the 
13
C chemical 
shift (Figure 27): 
  *     (∑        
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Figure 27: Principal scheme for the spherical code (5 spheres) and the artificial neural 
network. 
Training was performed with simple and resilient back-propagation of errors.  
Two back-propagation algorithms were applied, simple back-propagation 
110a
 and resilient back-
propagation
10a
 of errors. Back-propagation starts with a normal forward run through the ANN 
determining the output for a given input vector. The difference between ANN output and target 
output is recorded as prediction error which is now “back-propagated”. Starting with the output 
layer – i.e. backward – the error determines an adjustment to the weights layer by layer. Simple 
back-propagation is a gradient-based update algorithm with two adjustable parameters, the 
learning rate η and the momentum α. Resilient back-propagation is a recent improvement of the 
algorithm where the weight adjustment depends on the sign but not on the magnitude of the 
gradient. 
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Close to 185,000 
13
C chemical shifts were available for training.  
An ensemble of 17,336 molecules with 17,913 
13
C spectra was extracted from the NMRShiftDB 
104
 (www.nmrshiftdb.org) database which provided 
13
C chemical shifts for 185,099 carbon atoms. 
In a first step, 87 molecules missing bonds or containing atom types not considered in our 
encoding scheme (e.g., sodium) were removed. In a second step, the remaining 17,249 molecules 
were rectified by adding missing hydrogen atoms and charges.  
Atoms are sorted in 35 distinct groups.  
To describe each atom a list of atom types was derived empirically from the ensemble of 13,229 
molecules. Each atom type was defined by the element type, the number of bonds, the nominal 
charge, the number of electrons in bonds (i.e. double bonds, triple bonds, aromatic bonds), and 
the geometry at the center. The possible bond types are only given implicitly: The second carbon 
atom type describes both double-bonded and aromatic carbons, the third allenic and acetylenic 
carbons. This procedure yielded 35 distinct atom types summarized in Table 12. In the process of 
atom type determination all bonds are categorized into four groups: single, double, triple, or 
aromatic. 
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Table 12: Atom types: Each atom type is determined by the element type, the number of bonds, 
the charge, the number of electrons in bonds (to describe double, triple and aromatic bonds), and 
the geometry (linear, trigonal, and tetrahedral). 
 
bo
nds 
char
ge 
#e- in 
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geome
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frequen
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nds 
char
ge 
#e- in 
bonds 
geome
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H 1 0 1 - 236295 O 2 0 2 tetra 21214 
C 4 0 4 tetra 80884   1 0 2 - 15005 
 
3 0 4 trig 109761   1 -1 2 - 40 
 
2 0 4 lin 2416   2 1 2 trig 15 
 
1 -1 4 - 27 F 1 0 1 - 1469 
 
3 -1 4 trig 7 P 3 0 3 tetra 67 
N 3 0 3 tetra 1623   4 0 5 tetra 170 
 
2 0 3 trig 4898   4 1 3 tetra 11 
 
1 0 3 - 1167 S 2 0 2 tetra 2012 
 
4 1 3 tetra 75   1 0 2 - 247 
 
3 1 3 trig 61   3 1 2 tetra 18 
 
2 1 3 lin 37   4 0 6 tetra 440 
 
3 0 3 trig 6616 Cl 1 0 1 - 3145 
 
4 0 5 tetra 9 Br 1 0 1 - 1618 
 
3 0 5 trig 1013 I 1 0 1 - 339 
 
2 0 5 lin 46   2 1 1 tetra 10 
Si 4 0 4 tetra 310 Se 2 0 2 tetra 133 
B 3 0 3 tetra 270             
 
Special descriptors are introduced for π-conjugated systems   
Within conjugated systems a substitution on one side of the molecule can trigger a shift in the 
electron density distribution over large distances and change the shielding of a carbon atom many 
bonds away. To address this issue, all atoms of a molecule were distinguished as in contact or not 
in contact with the atom of interest via a conjugated π-system. One π-system is defined as a set of 
connected atoms that have a planar geometry and either lone-pair electrons or double, triple, or 
aromatic bonds. All these atoms in the direct neighborhood of the carbon atom of interest are 
grouped together and yield an additional set of numerical descriptors for input into the ANN. This 
procedure is similar to the one described by Meiler
109
. 
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The numerical description of the atom environment considers five spheres defined by molecule 
constitution.  
The numerical code describes the constitutional environment of each carbon atom. Since the 
ANN has a defined number of inputs, the environment code must be described by a vector of 
constant length. Furthermore, it is advantageous if every input of the ANN always encodes the 
same property.  
Centered on the atom of interest, n spheres in the network of chemical bonds are encoded (Figure 
28). The i-th sphere consists of all atoms that have a minimal distance of i bonds to the atom of 
interest. For a small molecule the outermost spheres with i > 5 are often sparsely inhabited. This 
was addressed by allowing those inputs to be zero if the distinct atom type or bond type is not 
present (see below). The encoding scheme relies only on the constitution of the molecule. The 
optimal number of spheres was determined to be five by systematically increasing n until no 
further improvement in the accuracy of 
13
C chemical shift prediction was observed. 
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Figure 28: An example for the sphere code for n=3 spheres: The atom of interest is the only 
element in sphere 0. The first sphere consists of nitrogen, sp2- and sp3-hybridized carbon. Their 
substituents constitute sphere 2. Sphere 3 contains two ring closures indicated by 3|3. 
 
Frequencies of atom and bond types in each sphere are input for the ANN.  
For the numerical code, the frequency of atom types in each sphere is determined. The first 
sphere – i.e. the atom of interest – can only contain one of five carbon atom types. Since 35 atom 
types are considered in a π-conjugated and non-π-conjugated state, this leads to 2*35*(n-1) inputs 
for the remaining spheres. Furthermore, the number of single, double, triple and aromatic bonds 
per sphere (4*n inputs) and the number of ring closures happening in this sphere are added (n 
inputs). Six inputs describe the physical properties of the solvent including molecular weight, 
boiling point, melting point, density, dielectric constant, and dipole moment. If the solvent was 
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unknown, chloroform would be assumed. The last input is the temperature at which the spectrum 
was taken. For n=5 spheres this leads to a total of 317 inputs. 
Constitutional and conformational descriptors utilize up to eight chemical properties.  
We implemented 2D/3D auto-correlation and radial distribution functions to describe the 
constitution and conformation of the molecule (Table 13) based on a similar approach to 
ADRIANA
5
. 
Table 13: 2D/3D auto-correlation and radial distribution functions 
Descriptor Name Description 
2D Autocorrelation (2DACorr)  
3D Autocorrelation (3DACorr) 
Radial Distribution Function (RDF) 
11 descriptors (d=11) 
12 descriptors (d=12) 
128 descriptors (d=128) 
*_Ident  weighted by atom identities 
*_SigChg weighted by σ atom charges 
*_PiChg weighted by π atom charges 
*_TotChg weighted by sum of σ and π charges 
*_SigEN 
weighted by σ atom 
electronegativities 
*_PiEN 
weighted by π atom 
electronegativities 
*_LpEN 
weighted by lone pair 
electronegativities 
*_Polariz 
weighted by effective atom 
polarizabilities 
  
σ-charge was implemented utilizing Partial Equalization of Orbital Electronegativity (PEOE, 115), 
π-charges were calculated by identifying conjugated systems and solving the according Hueckel-
matrices. The Hueckel parameters were taken from 
125.  Total charge is the sum of σ- and π-
charge. The electronegativities were determined from the charges by means of a quadratic 
polynomial fitted through charges -1, 0, and +1
115, 119
. The determination of polarizability is 
detailed in 
126
. The codes are all centered on the atom of interest and sum up a certain property of 
each atom in a certain distance (interval) from the atom of interest. 
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The formula for 2D auto-correlation:      ∑  , d=0, …, 10, where pd is the property of each 
atom that is d bonds away. 
The formula for 3D auto-correlation:      ∑  , d=0, …, 11, where pd is the property of each 
atom with a Euclidean distance between d and (d+1)Å. 
The formula for RDF:      ∑    
              , d=0, …, 127, where pd is the property of 
each atom with a Euclidean distance d’ from the atom of interest, effectively measuring distances 
between 0 and 12.7Å. 
This leads to a total of 1208 descriptors. For an illustration how configurational changes are 
captured by the radial distribution functions see Figure 24. 
Descriptors are sorted by input sensitivity to improve prediction accuracy.  
To determine the significance of each input the ANN is considered to be a multidimensional 
function 
                
with input values x1,…,xn and output y. Then the sensitivity of each input can be measured by 
determining the partial derivative 
   
   
. 
For categories containing multiple descriptors, the square norm of the sensitivity of all inputs is 
considered as total sensitivity. 
A single ANN is trained to predict the chemical shift of all 
13
C atoms.  
The advantage of this encoding scheme is its flexibility: Each molecule and each atom of interest 
can be encoded with the same scheme and therefore predicted by a single ANN. This is in 
contrast to previous work 
109
, where a distinct encoding scheme and ANN was used for each 
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carbon atom type. The switch to a single ANN was prompted by the significantly smaller 
database of spectra available for determining the parameters of the ANNs. The more generic 
encoding scheme allows for a single ANN with fewer parameters.  
Training was accelerated using recently optimized training algorithm.  
To train the network, Resilient Propagation
10
, an adaptive gradient-based algorithm, was 
implemented. It constitutes a faster learning algorithm than standard back-propagation of errors. 
However, due to oscillating behavior of the resilient back-propagation after an initial optimization 
of 20,000 steps, the final optimization was carried out with up to 700,000 steps of simple back-
propagation. During the simple back-propagation, the learning rate η was reduced from 0.1 to 
0.001, the momentum α was increased from 0.5 to 1.0. The training took place on a RedHat 
Scientific Linux workstation with 2GB RAM and 2 Intel Pentium D processors (3.2GHz). The 
total time required for training the ANN amounted to 2 weeks. 
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CHAPTER VI 
DISCUSSION 
Conclusions and future directions 
Quantitative Structure Activity Relations 
The trained neural networks established very stable quantitative structure-activity relationships 
for metabotropic glutamate receptors. The quality measures of root mean square deviation, area 
under the ROC curve and enrichment are comparable for all three models. The strength of the 
models lies more in predicting if a compound will be active or not (a binary decision) based on a 
certain cut-off rather than in exactly predicting the potency of a given molecule (hence the large 
overall rmsd values). This could be based on the fact that all inactive compounds were set to an 
arbitrary potency of 1mM where the correct values are spread out over a certain range. However, 
the enrichment is only based on picking the right compounds below the aforementioned cut-off, 
making it the most reliable quality measure employed in these experiments. An interesting 
question would be if setting the inactive compounds to a different value, e.g., 100µM, influences 
the quality of the models. While reducing the distance between the least active and the inactive 
compounds, it would augment the differences in activity between the active compounds. Another 
improvement to the model quality could consist in finding a way to distinguish inactive 
compounds by their level of inactivity. The first thing that comes to mind is expanding the range 
of the concentration response curve experiments. Furthermore, if a different assay for the same 
target and small molecules is available, its data could be incorporated in the same model. Also, if 
additional experimental data like solubility of the compound could be collected during the high-
throughput screen, these data could reinforce or even replace some of the computed descriptors 
like calculated logP. One way to enhance the model quality without performing additional high-
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throughput experiments consists of training models on other data collected or derived in the 
original HTS like minimum and maximum of glutamate response or efficacy. Taking this idea to 
its natural conclusion, all thirty experimental data points per compound (ten concentrations in 
triplicate) could be predicted allowing the differences in the quality of the curve and its 
confidence levels to inform the model. In such a model, positive and negative allosteric 
modulation of the same target could be described simultaneously, since they are represented by 
differently shaped curves in the same concentration response curve experiment, where EC50 and 
IC50 cannot be encoded by the same output due to their different nature. This would substantially 
increase the rate of actives over inactive possibly leading to better models. Training times for the 
models should be similar if only the number of output is increased because the number of degrees 
of freedoms (weights) will only be slightly larger. However, it could be necessary to employ 
more hidden neurons due to the larger dimension of the output space which would increase 
training times. 
Encoding the drug molecules through chemical descriptors ensures that the activity of each 
possible molecule can be determined by the trained models independent from the molecule's 
orientation in space. The actual conformation of the molecule is captured by the 3D descriptors 
which consistently play an important role in each final model. However, each molecule is only 
represented by one conformation computed by the CORINA software package without any 
knowledge of the target protein. Therefore, the actual conformation of the bound molecule will be 
substantially different from this one computed conformation. One way to alleviate this problem 
without a priori knowledge of the protein is to compute a conformational ensemble of the 
compound in question. This works especially well for the active compounds which are 
oversampled to begin with: Each instance of the balanced data set could represent a different 
conformation of the small molecule. 
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All three models allowed the identification of previously unknown compounds. The virtual high-
throughput screen was performed on the external ChemBridge and ChemDiv compound libraries 
that were also the building blocks for generating the Vanderbilt high-throughput screening center 
collection of molecules. Screening these larger libraries could be biased towards predicting 
similar compounds to the known active ones. A future experiment should be conducted to 
determine if screening compound libraries unrelated to the ones employed in creating the library 
the model is trained on would lead to a higher percentage of compounds representing novel 
scaffolds. 
Automated feature selection and training of the neural networks allows greater flexibility in 
selecting novel targets and collaborating with other scientists. So far, the overall experiment 
involves several manual steps. Integrating the overall work flow in an existing database solution 
for high-throughput screening like Pipeline Pilot would make this approach an integral part of 
many drug discovery projects. 
Final models for all three QSARs were integrated into a web server predicting the activity of a 
given molecule towards positive and negative allosteric modulation of metabotropic glutamate 
receptor subtype 5 and positive allosteric modulation of subtype 4. Currently, the web server is 
only available in the Vanderbilt Drug Discovery program and is employed to routinely check 
compounds for their usability as allosteric modulators of mGlu4 and mGlu5.  
All neural networks were trained on a subset of ADRIANA descriptors. The inclusion of other 
sets of descriptors could improve the neural networks' capability to correctly describe additional 
chemical features that increase the enrichment of active compounds in virtual high-throughput 
screens. The overall size of the model could be kept similar to the existing models by removing 
more descriptors during the feature selection process. 
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Different methods were assessed to determine the importance of each descriptor category. In a 
first implementation of the feature selection, the mean of the descriptor sensitivities in each 
category was employed to rank them. In a second approach, the Euclidean sum of the sensitivities 
was the decisive criterion. This put more emphasis on the larger descriptor categories like radial 
distribution functions (128 inputs each). Other methods of ranking the descriptors could better 
evaluate each category's importance. Reducing the number of bins for radial distribution 
functions would provide another way to balance the descriptors. 
Four of the biggest questions remaining are: (a) Can this approach be easily transferred to other 
receptors? An attempt to answer this question can be found in an upcoming paper that 
benchmarks this method for such targets as the M1 muscarinic receptor. The general setup of the 
computational workflow allows for easy application to different HTS. (b) What is the smallest set 
of compounds with known activities needed for this approach? I. e., what size of a high-
throughput screen would allow virtual high-throughput screening? Leading directly to (c) How 
can the iterative approach be expanded towards an automated way of improving the overall 
quality of the neural network prediction? Based on the observation that the 3D descriptors play an 
important role in each of the final models another interesting question is (d) Does the quality of 
the models improve if an ensemble of low-energy conformations is employed in describing the 
molecules? This could help capturing differences in the conformations of bound and unbound 
molecules, even without necessarily knowing the conformation of bound molecules in a 
target/drug complex. 
Metabotropic glutamate receptor 5 PAMs 
The high ratio of confirmed metabotropic glutamate receptor subtype 5 positive allosteric 
modulators in the high-throughput screen allowed for the training of very stable models, resulting 
in a high enrichment that is similar over the range of models trained. 
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It is known that there are at least two allosteric sites for positive modulation of mGlu5 
representing two or more different scaffolds. The general approach allowed describing 
modulators for both sides in a single model. This led to a broad range of novel mGlu5 PAMs 
being discovered. 
Even if the majority of the high-throughput screening results are published, results of small 
screens for mGlu5 PAMs should be incorporated into the existing models by training the ANNs 
on this additional data. Additional PAMs could reduce the need to balance the data set between 
active and inactive compounds. After the drug discovery efforts for mGlu5 PAMs are finalized, 
the trained model should be made publicly available to allow incorporation into future drug 
discovery efforts toward this target. 
Metabotropic glutamate receptor 4 PAMs 
The set of positive allosteric modulators towards metabotropic glutamate receptor subtype 4 
identified by high-throughput screening was significantly smaller than the set of PAMs for 
subtype 5. Furthermore, the 434 PAMs showed a high degree of similarity. This could be one of 
the reasons for the lower enrichments compared to the model for mGlu5 PAMs. 
The designed experiment consisted of two rounds of collecting data, training models, and 
predicting mGlu4 PAMs. This allowed for the possibility of incorporating the results of a virtual 
high-throughput screen in an iterative fashion to improve the quality of the trained model. 
Furthermore, the second round aimed at increasing the possibility for scaffold hopping by 
choosing a higher cutoff for predicting compounds as being active. This further reduced the 
enrichment. 
The mGlu4 PAM vHTS experiment clearly was the most difficult one in terms of the available 
data. The main result here is the transferability of the approach from mGlu5 to a subtype of a 
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different group of metabotropic glutamate receptors. Even while active molecules with non-trivial 
modifications from known actives were found, true scaffold hopping did not occur. 
New screening results for mGlu4 PAMs should be incorporated into the existing model. After the 
drug discovery efforts for mGlu4 PAMs are finalized, the model should be disclosed. 
Metabotropic glutamate receptor 5 NAMs 
Being the last of the three experiments to predict modulators of metabotropic glutamate receptors, 
this model greatly profited from the experiences with the first two. Descriptor selection and 
iterative approach proved valuable in generating true scaffold hopping. Two molecules with 
approximately 100nM potency each were discovered in the set of molecules predicted to be active 
by the model.  
The SAR around these two molecules proved to be very narrow which disqualifies them as lead 
compounds for developing new drugs. The compounds could still be employed as probe 
molecules. 
The experimental data will be published together with animal model behavioral studies and 
strong biological data for the two novel NAMs. 
Carbon chemical shift prediction 
Artificial neural networks were trained in a quantitative structure property relation experiment 
(QSPR) to predict carbon chemical shifts. All neighbors of an atom of interest were organized in 
spheres. The distribution of atom types in these spheres together with bond and ring descriptors 
served as input for the neural networks. A web server was implemented based on this universal 
model which is publicly available.  
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Based on the ADRIANA descriptors, radial distribution functions describing the distribution of 
atoms in the three-dimensional space around the atom of interest were developed. These allowed 
the neural network to distinguish between different configurations and conformations. Including 
these descriptors into the input for each atom of interest greatly improved the quality of the 
model. 
Increasing the number of data points by identifying freely available chemical shift databases will 
improve the quality of the trained models. Another source could be locally collected spectral data 
through a web tool designed by Bill Graham after discussion with Don Stec and Ralf Mueller. 
This tool could also help in transferring carbon spectra from the literature to a local database.  
In the future, the influence of different machine learning approaches (e.g., support vector 
machines) on the quality of the models should be evaluated.  
Other steps to improve the quality and the usability of the QSPR models could be the inclusion of 
other spectra, especially proton spectral data, expansion of the descriptor base drawing on the 
overlap with the metabotropic glutamate receptor experiments, and applying descriptor 
optimization techniques described in the QSAR chapters. 
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APPENDIX 
General comments 
The computational work presented here is based on applications programmed in the BCL. 
Command lines will usually employ a compiled version of the BCL (“apps_release.exe”). A 
recent version of the BCL executable is available by executing “bcl.exe”. However, to modify 
existing applications it is necessary to check out a local copy of the BCL repository. 
The command lines and applications reported here span five years of development in the BCL. 
The description of the data in the files was changed several times to reflect improvements in the 
object design in the BCL. Therefore it can become necessary to adjust headers or structures of 
data files to the most current version represented in the BCL. A general understanding of a 
scripting language like awk, perl, or python will prove beneficial in this task. 
General explanations for each subdirectory are in READ_ME.txt files which can be looked at for 
instance with less or any text editor like vi. Output of specific command lines was redirected into 
log files usually starting with “fun” and containing the specific BCL application in their name.   
QSAR data structure 
The QSAR projects described in chapters II to IV share a very similar data structure: under 
/QSAR/ are subdirectories named after each of the QSAR chapters: mGlu5_PAM, mGlu4, 
mGlu5_NAM. Each folder contains subdirectories for all trained models distinguished by the 
number of descriptors, e.g. “1252descriptors/” for a model employing all of the ADRIANA 
descriptors. Executable files compiled specifically for the given data are collected in 
“executables/”. These should especially be employed in cases were the current version of the 
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BCL fails to process data files. Collections of molecules that were predicted with the trained 
models are stored in SD files under “sdf/”. 
QSAR applications 
After collecting SD files for the active and inactive molecules for a given drug target, the active 
compounds needed to be oversampled due to the usually low rate of active compounds in the set 
of all molecules. To remove active molecules from the data set of all molecules tools like „sdsort‟ 
can be utilized. The „combine_sm_ensembles.exe‟ application loads the SD files containing the 
active and inactive compounds into small molecule ensembles, determines the enrichment factor, 
randomizes both ensembles, oversamples the smaller small molecule ensemble to a similar size to 
the larger ensemble and folds the two ensembles together before writing it out to a combined SD 
file. „Folding‟ means alternating between active and inactive compounds which ensures an even 
distribution of active and inactive compounds in the training, monitoring, and independent data 
set. The randomization has to be done before the oversampling and folding to avoid the 
distribution of the independent active molecules to the monitoring and training data sets. 
The „apps_release.exe GenerateSmallMoleculeCode‟ application computes the input for training 
an ANN or other type of model from a given SD file and code object. The code object is a list of 
descriptors available in the BCL, mostly based on re-implementations of ADRIANA descriptors. 
The output is stored in .dat-files which are lists of pairs of vectors. Each pair of vectors represents 
the input and according output calculated from one molecule (molecule-based descriptors). 
The training of the ANNs was realized through the „apps_release.exe TrainANN‟ application 
which allows the specification of the architecture/geometry of the ANN, the number of training 
steps, the training algorithm, etc. 
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Trained ANNs can be employed in applications like the web server „PredictQSAR‟ predicting the 
activity of a given small molecule towards mGlu5_NAMs/PAMs and mGlu4_PAMs, and 
„ComputeQSARRange‟ determining all small molecules with predicted activities in a specified 
range. 
QSAR/mGlu5_PAM 
The mGlu5 PAM project is the oldest QSAR project described in this document. Most of the 
tools described here were developed while undertaking it. Input and output were described in the 
same vector. Subsets of 20,000 small molecules can be found in the „generate_data_*‟ 
subdirectories where dat-files were created from the ADRIANA descriptors stored in the SD file. 
Enrichment was determined manually and the overall dat-file generated by randomizing and 
folding the data vectors employing awk lines developed by Kristian Kaufmann. 
The descriptor selection process was performed in „mGlu5‟ where csv-files for different sets of 
descriptors represent the different stages of descriptor optimization. The files are not designated 
by the number of descriptors but instead list all descriptor categories employed in the actual 
model. 
Eric Dawson trained the ANNs from 428 down to 136 descriptors and the scalar model with 8 
descriptors. The results can be found in „/home/dawsones/qsar/encode/Adriana/HTS/ 
mol_descriptor‟. A local copy can be found under „models_eric‟. 
The „ChemBridge‟ folder contains all results for the virtual HTS described in chapter II. 
Furthermore, the folder holds scaffold hopping experiments which were abandoned due to the 
wealth of known mGlu5 PAMs and focus on the other QSAR experiments described in chapter 
III and IV. 
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QSAR/mGlu4_PAM 
The active compounds are stored in sdf/mGlu4_Vandy_confirmed_Nov08.sdf.bz2. The file with 
the ADRIANA descriptors is in the same directory. The inactive compounds of the HTS at 
Vanderbilt are stored in minus_confirmed/all.sdf. 
Purging describes the process of removing mostly charged small molecules which were missing 
ADRIANA descriptors. Descriptors were generated from all_combined.sdf. 
The trained models and the jury can be found in the respective directories. The first trained jury 
had different independent data sets for the 415, 578, and 741 descriptor models which were fixed 
in old_same_independent. The scaffold hopping experiments were performed together with Thuy 
Nguyen (/home/nguyent8/Projects). A local copy can be found in scaffold_hopping/Projects. 
QSAR/mGlu5_NAM 
The SD files with the active (HTS_mGlu5_NAM_adriana.sdf.bz2) and inactive compounds 
(Vandy_Library_minus_mGlu5_NAM_adriana.sdf.bz2) can be found in the sdf directory. The 
randomized, balanced, and folded SD file is code.sdf.bz2. 
The trained models are in their respective subdirectories together with the corresponding dat-files. 
The prediction of active compounds at different cut-offs, the filtering of these small molecule sets 
by different criteria, and the generation of the compound orders was done by Eric Dawson 
(/home/dawsones/mGlu5_NAM). A local copy can be found under analysis_eric. 
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 Predict_chemical_shifts data structure  
The predict_chemical_shifts subdirectory contains the work connected to chapter V. Each 
„datagen200*‟ subdirectory consists of (modifications to) an implementation of an atom-centered 
code, data generation based on this code, ANN training, and optimization of code parameters like 
number of spheres around the atom of interest and ANN parameters like number of hidden 
neurons. For comparison, the models reported in Meiler 2002 were retrained in the 
„ANNnew100nmr*‟ subdirectories. 
The two main data bases employed in the training of the carbon chemical shift models can be 
found under „data_bases/NMRshiftDB‟ and „data_bases/CSD‟. Dihedral angle histograms for all 
pairs of atom types found in the CSD were generated in „histos‟. 
Test sets of different small molecules are stored under „sdf‟. References can be found in the 
„references‟ subdirectory. 
Additional information can be found in the READ_ME.txt and fun*.log files in the according 
subdirectories. 
Predict_chemical_shifts/ applications 
The overall approach is similar to the QSAR projects. After generation of the input data 
(*.dat.bz2) from the SD files ANNs are trained employing the „apps_release.exe TrainANN‟ 
application. However, due to the different approaches for code generation different „apps_release 
GenerateCSCode‟ applications exist. The details will be discussed in the following paragraphs. 
Usually, it is unnecessary to balance and fold the data set. In one experiment it was tested to 
balance molecules with high deviations (small data set) against molecules with low deviations 
(large data set) but improvements were negligible. 
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quality_assurance/ 
To provide conformational data for the small molecules in NMRshiftDB, the overlap between 
NMRshiftDB and Cambridge Structural Database was determined employing the „own‟ library 
written by Jens Meiler. The local copy under „small_molecule/own‟ was modified to include 
specific „WriteInMDLFile‟ functions in the molecule and ensemble classes. A total set of 6,418 
small molecules was identified being in both databases. This approach was later replaced by 
employing CORINA to determine a low-energy conformation for all small molecules in the 
NMRshiftDB. 
 histos/  
In this directory dihedral histograms were determined for all atom type pairs in the CSD. A list of 
38 common atom types in the CSD was compiled. All occurrences for each combination of these 
38 atom types with each other were measured for the dihedral angles including them and their 
substituents. The resulting angles were binned by 10° steps leading to a sparsely populated 38 x 
38 x 36 tensor („dihe_csd_20071029.csv‟). Another histogram was generated excluding atoms in 
rings to remove bias towards common ring dihedrals („dihe_csd_no_rings_20071029.csv‟). This 
work was utilized in Kaufmann „Small Molecule Rotamers Enable Simultaneous Optimization of 
Small Molecule and Protein Degrees of Freedom in RosettaLigand Docking‟. 
datagen20*/ 
The carbon chemical shift prediction work presented in chapter V is organized in folders called 
„datagen20*‟ usually including the date of their creation. They include modifications of earlier 
implementations of the chemical shift code and ANNs testing these modifications. 
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datagen20070321/ 
Before the generation of the actual code the „nmrshiftdb_csd_part.sdf‟ was prepared by fixing 
missing hydrogens, removing molecules missing bonds or having undetermined atom types. 
Aromaticity was determined and a list of solvents created to be represented in the BCL. A subset 
of seventeen uncharged atom types was employed to generate a smaller data set without charged 
atoms. Executables were created to prepare the small molecule ensemble (BCL), sort out given 
atom types (BCL), combine the NMRshiftDB and CSD (own), determine the      for individual 
molecules and the whole ensemble (own), and analyze the occurrence of given fragments in the 
small molecule ensemble. 
datagen20071011 
A new 2D code was introduced to provide more detail how atoms are connected to the atom of 
interest. 
General structure of the 1D-code 
The code contains the sum of atom types for a certain amount of spheres around the atom of 
interest, first all atom types (n per sphere), second only atom types conjugated with the atom of 
interest (n per sphere). Furthermore the sum of bond types (8 per sphere) in each sphere and the 
ring closure number (1 per sphere). The last 7 inputs are solvent properties. The output is the 
chemical shift of the atom of interest. 
 
General structure of the 2D-code 
The code differs from the 1D code by providing a matrix combining bond and atom types. This 
gives number bond types * number atom types per sphere, once for all and once for conjugated 
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atom types. For the first sphere (atom of interest) only the carbon atom type (2*5 inputs) was 
given. Ring closure numbers, solvent properties and output are the same like 1D. 
ANNs were trained for both codes over a hidden neuron range from eight to 128 and for the full 
set of atom types and the reduced set of uncharged atom types. The number of spheres around the 
atom of interest was varied between five, seven, and eight. 
datagen20080110 
Here outliers above 20ppm were removed and ANNs with 64 hidden neurons trained on the 1D 
and 2D code. Afterwards, the small molecules were split into molecules having maximal 
chemical shift deviation per atom above 12ppm and below 12ppm. The smaller set above 12ppm 
was balanced against the larger set below 12ppm to train the models on these outliers. However, 
no substantial improvement in overall      was found. 
datagen20080110 
Building on the earlier results, the cut-off was optimized to 17ppm. Outliers were scrutinized and 
different atom types of phosphorus tested. The number of hidden neurons was set to 48. 
datagen20081205 
Codes based only on connectivity and codes implementing conformational descriptors 
(RDF_Ident, 64 descriptors, and 0.1Å) were created from NMRshiftDB to test the influence of 
the stereochemical descriptors. Both codes consist of 5 spheres around the atom of interest. Both 
networks have 48 hidden neurons. Even if the ANNs were still improving, it is clearly visible 
from Figure 29 that adding stereochemical descriptors improves the overall quality of the ANN. 
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Figure 29: Influence of the stereochemical descriptors on the overall quality of the trained 
ANNs: ANNs improve after inclusion of the RDF_Ident stereochemical descriptors. 
datagen20090225/ 
To identify problems with the existing code an ANN was trained on random 10% of the 
NMRshiftDB data (18,607 data points including RDF_Ident stereochemical descriptor) revealing 
several short-comings of the protocol established so far. Atoms of interest containing silicon in 
their environment showed large deviations probably due to the small number of molecules with 
silicon. 
The geometry of some molecules was not correct leading to wrongly placed hydrogens and 
therefore erroneous stereochemical descriptors. One molecule had a carbon chemical shift 
assigned to a hydrogen atom. The BCL method adding missing hydrogens produced clashes if a 
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sp3-carbon already had three substituents with 120° which can be fixed by generating low-energy 
conformations with CORINA. 
Several shifts reported in the NMRshiftDB are wrong compared to similar structures in the 
literature.  
It proved problematic to describe quinone-like structures as being aromatic. 
datagen20090226 
Based on the results so far, a whole workflow was designed aimed at improving the quality of the 
input files to the ANNs. A new version of NMRshiftDB was downloaded. CORINA was 
employed to create low-energy conformations and add missing hydrogen atoms. The solvents 
reported in the NMRshiftDB were mapped to a small set of known solvents in the BCL. 
Aromaticity was determined through a script created by Kristian Kaufmann.  
Eight molecules missing hydrogen atoms were checked revealing steric clashes that apparently 
were not resolved by CORINA. These molecules were sorted out. Approximately 200 molecules 
missing charges could be fixed through BCL methods. 
A random 1% subset of molecules was checked manually for obvious errors: (i) hydroxyl groups 
are sometimes not in plane with benzene, (ii) conjugated systems are sometimes not planar, (iii) 
two benzenes connected by a sp3-hybridized carbon have overlapping π-clouds, (iv) carbon-
sulfur bonds in one ring were too long, (v) para-substituted pyrine between two benzenes is not 
planar, and (vi) two nitrogen neighbors should be sp3-hybridized.  
After addressing these errors the whole ensemble was randomized 
(ensemble_random_100pct.sdf). The first 10% of all molecules were set aside as independent, 
second 10% as monitor, and the remaining 80% as training data set. 
126 
 
datagen20090423 
After implementing the atom-based descriptors an ANN was trained based on the conformational 
code (2D/3DAutoCorr, RDF) on 10% of the data (18,306 data points). The input sensitivity 
analysis showed that the lone-pair electronegativity descriptors carried the least information. 
Checking the code revealed an error in the implementation which was fixed subsequentially. 
datagen20090519 
Repeating the analysis with the fixed LpEN descriptors generated the input sensitivity data 
reported in chapter V. 
datagen20090604 
A descriptor optimization experiment was performed based on input sensitivity analysis. Models 
with 1,525, 1,166, 701, and 509 descriptors were trained. The results were inconclusive. 
datagen20100714 
A first implementation of the substituent code was developed in collaboration with Laura Wiley. 
It included descriptors for atom types, bonds, and ring closure. However, conjugated systems near 
the atom of interest were not described. Furthermore, the substituents were not ordered according 
to their bond order and atomic weight. 
datagen20110226 
After adding the ordering of the substituents and the description of conjugated systems, the final 
models so far were trained. Each combination of atom type and number of hydrogen atoms got its 
own subdirectory. The optimal number of neurons was determined at 32. Three and four sphere 
codes (datagen20110306/ ) were tested, but for the larger data sets like sp2_c the training of the 
ANNs remained incomplete due to the exponential increase of the number of descriptors. 
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TrainANN.pbs scripts were employed to perform a five-fold cross-validation (cv_0-0  ... cv_0-4) 
on the piranha cluster in the Center for Structural Biology at Vanderbilt. The first 10% of the data 
set always represented the independent data set. The monitoring data set was varied from the 
second to sixth 10%. Taking out approximately 10% of the outliers greatly improved the overall 
predictions. Different cutoffs were determined for all atom type/#hydrogen atoms combinations. 
The results can be found in „reduced_*ppm‟ subdirectories. Under „reduced_*ppm_new_nn‟ new 
models were trained based on the reduced data sets. 
similarity_search/ 
The clusters of small molecules shown in Figure 5, Figure 13, and Figure 15 are based on 
determining the largest connected common substructure between two given molecules. An 
algorithm published by Krissinel in 2004 was implemented in the BCL. However, since this 
algorithm allows unconnected substructures (bond order 0), it was modified to allow specifying if 
the substructure should be connected or not. Testing results for correctness and speed can be 
found under „similarity_search‟. The BCL classes for this algorithm are 
graph::CommonSubgraphIsomorphismBase and CommonSubgraphIsomorphismWithUserGraph. 
The application for generating the small molecule distance matrices utilized to generate the 
clusters is „apps_release.exe DetermineCSIMAtrix‟.  
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